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Summary 
 
The tolerance of Enterococcus mundtii ST4SA to stressful gastro-intestinal conditions in 
humans and animals is vital to its success as a probiotic. The need for new effective 
probiotics with stronger inhibitory (bacteriocin) activity has arisen due to the increasing 
number of antibiotic resistant pathogens. Enterococci are used in the fermentation of 
sausages and olives, cheese making and as probiotics. Their role as opportunistic 
pathogens in humans makes them a controversial probiotic (Moreno et al., 2005). 
Enterococci occur naturally in the gastro-intestinal tract which renders them intrinsic acid 
and bile resistance characteristics. E. mundtii ST4SA produces a 3950 Da broad-spectrum 
antibacterial peptide active against Gram-positive and Gram-negative bacteria, and 
viruses. The bacteria include Enterococcus faecalis, Streptococcus spp., Pseudomonas 
aeruginosa, Klebsiella pneumoniae, Streptococcus pneumoniae and Staphylococcus 
aureus. E. mundtii ST4SA inactivates the herpes simplex viruses HSV-1 (strain F) and 
HSV-2 (strain G), a measles virus (strain MV/BRAZIL/001/91, an attenuated strain of 
MV), and a polio virus (PV3, strain Sabin). 
 
This study focuses on the genetic stability of E. mundtii ST4SA genes when exposed to 
stress factors in the human and animal gastrointestinal tract. Based on results obtained by 
real-time PCR, the  expression of genes encoding bacST4SA, RecA, GroES and 23S 
rRNA by E. mundtii ST4SA were not affected  when the cells were exposed to acid, bile 
and pancreatic juice. This suggests that these genes of E. mundtii ST4SA will remain 
stable in the intestine. This could indicate that other genes of E. mundtii ST4SA could 
remain stable in the host. Further studies on the stability of genes encoding antibiotic 
resistance and virulence factors should be conducted to determine their stability and 
expression in the host in stress conditions. Concluded from this study, E. mundtii ST4SA 
is an excellent probiotic strain.  
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Opsomming 
 
Enterococcus mundtii ST4SA se weerstandsvermoë teen stresvolle gastrointestinale 
kondisies is essensieel vir die sukses van hierdie organisme as ‘n probiotikum. Die 
aanvraag vir nuwe, meer effektiewe probiotika met sterker inhibitoriese (bakteriosien) 
aktiwiteit is as gevolg van die toename in antibiotikum weerstandbiedende patogene. 
Enterococci word algemeen gebruik as probiotika, sowel as in die fermentasie van worse, 
olywe en kaas. Hulle rol as oppertunistiese patogene in mense veroorsaak kontroversie as 
gevolg van hul toenemende gebruik as probiotika. Enterococci is deel van die natuurlike 
mikroflora in die gastrointestinale weg van mense en diere. Dit verleen aan hierdie 
spesies ‘n natuurlike weerstandsvermoë teen maagsure, galsoute en pankreatiese 
afskeidings. E. mundtii ST4SA produseer ‘n 3950 Da wye spektrum anti-bakteriese 
peptied, aktief teen Gram positiewe en Gram negatiewe bakterieë sowel as  virusse. 
Hierdie bakterieë sluit Enterococcus faecalis, Streptococcus spp., Pseudomonas 
aeruginosa, Klebsiella pneumoniae, Streptococcus pneumoniae en Staphylococcus 
aureus in. E. mundtii ST4SA inaktiveer die herpes simpleks virus HSV-1 en HSV-2, ‘n 
masels virus (MV/BRAZIL/001/91), en ‘n polio virus (PV3, stam Sabin). 
 
Hierdie studie fokus op die genetiese stabiliteit van E. mundtii ST4SA gene, wanneer 
hulle blootgestel word aan stress faktore in die mens en dier gastrointestinale weg. 
“Intydse” PKR data gebasseer op die uitdrukking van die bacST4SA, RecA, GroES en 
23S rRNA gene in stresvolle kondisies dui aan dat E. mundtii ST4SA nie geaffekteer 
word wanneer die sel blootgestel word aan suur, gal en pankreatiese vloeistowwe nie. 
Hierdie resultate dui aan dat hierdie gene van E. mundtii ST4SA stabiel sal bly in die 
intestinale weg van die mens en dier. Dit kan aandui dat ander gene van E. mundtii 
ST4SA soos die wat kodeer vir virulensie faktore en antibiotikum se weerstandsvermoë 
stabiel mag bly in die gasheer. Verdere studies wat fokus op die stabiliteit van gene wat 
kodeer vir antibiotikum weerstandbiedendheid en virulensie faktore moet uitgevoer word 
om hulle stabiliteit en uitdrukking in die gasheer te bepaal. Bevindings van hierdie studie 
dui aan dat E. mundtii ST4SA goeie potensiaal het as ‘n probiotikum. 
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INTRODUCTION 
 
Lactic acid bacteria were among the first microorganisms to be used in food manufacturing, 
contributing to flavour, texture and preservation of fermented foods (De Vuyst and Vandamme, 
1994). They are used in various processes, including fermented milk products, vegetables and 
meat, cheeses, and wine fermentation. Recently, the health industry has gained interest in lactic 
acid bacteria. Health promoting benefits of fermented foods containing lactic acid bacteria has 
been known since the early nineteen hundreds (Metchnikoff, 1908). Lactic acid bacteria produce 
bacteriocins that has numerous applications and possibilities in the food and health industry 
(Ennahar et al., 2000). Bacteriocins may replace antibiotics in the near future, overcoming the 
problem of multi-drug resistant pathogens. The medical industry focuses on class II bacteriocins 
because some has potent anti-viral properties (Richard et al., 2006).  
 
The intestinal tract is a complex ecosystem, containing at least 50 genera of bacteria and 
hundreds of species (Finegold et al., 1974). Most probiotics reside in the colon where they 
provide health, therapeutic and nutritional benefits to the host. These include reduction of blood 
cholesterol, deconjugation of bile acids, improvement of lactose utilization and increased 
immunity. Probiotics maintain equilibrium between beneficial and potential pathogenic bacteria 
in the host (Gagnon et al., 2004).  
 
The gastrointestinal tract is an oxygen depleted, nutrient rich, and ecologically complex 
environment (Flahaut et al., 1996). Probiotic bacteria has to survive numerous stress factors such 
as low pH in the stomach, high levels of pancreatic juice and bile salts in the upper duodenum 
and competition with other microorganisms in the lower duodenum. For these reasons potential 
probiotics has to be tested for traits such as bacteriocin production, absorption to epithelial cells, 
antibiotic resistance, and hemolytic activity. Probiotics has to be non-pathogenic, resistant to acid 
and bile and colonize the intestinal ecosystem (Gagnon et al., 2004).  
 
Enterococcus mundtii occurs naturally in the human intestine. E. mundtii ST4V produces a 
broad-spectrum bacteriocin active against Gram-positive and Gram-negative bacteria and viruses 
(Todorov et al., 2005). Class II bacteriocins are heat-stable peptides, less than 10kDa in size and 
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does not contain modified amino acids. They has a highly conserved N-terminal domain and at 
least one disulfide bridge (Richard et al., 2006).  
 
The use of enterococci as probiotics remains a controversial issue. Probiotic benefits of some 
enterococci are well documented, but the emergence and increased association of enterococci 
with human disease and multiple antibiotic resistances has raised some concern (Moreno et al., 
2006). Enterococcus mundtii, however, has GRAS (generally regarded as safe) status. This study 
focuses on the genetic reaction of Enterococcus mundtii ST4SA in conditions simulating stress in 
the gastrointestinal tract. Gene expression of the genes encoding bacST4SA, RecA, GroES and 
23S rRNA was recorded by real–time PCR.  
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LITERATURE STUDY 
1. LACTIC ACID BACTERIA  
 
Introduction 
Lactic acid bacteria (LAB) are Gram-positive, non-sporulating, microaerophilic bacteria that 
produce lactate as main end product from the fermentation of carbohydrates. The genera include 
Lactococcus, Vagococcus, Leuconostoc, Pediococcus, Aerococcus, Tetragenococcus, 
Streptococcus, Enterococcus, Lactobacillus, Melissococcus, Oenococcus, Weissella, 
Carnobacterium and Bifidobacterium. Some LAB, such as Lactobacillus spp., Bifidobacterium 
bifidum and Enterococcus faecium, form part of the natural gastrointestinal microflora in humans 
and animals. A number of species are used as starter cultures in the production of yogurt and as 
probiotics in animal feed and food supplements. LAB promotes aroma and flavour development 
in foods. The main nutritional and therapeutic effects of these organisms, as described by De 
Vuyst and Vandamme (1992) are: 
• Production of vitamins (e.g. folic acid) and enzymes (e.g. lactase).  
• Improvement of the overall quality and nutritional value of food and animal feed. 
• Stabilization of intestinal microflora and reduction in colonization of pathogenic bacteria. 
• Protection against intestinal and urinary tract infections by production of antimicrobial 
substances, including bacteriocins. 
• Reduction in the level of cholesterol in the blood serum by cholesterol assimilation, bile 
salt hydrolysis and modulation of the ratio of high-density to low-density lipoprotein. 
• Decreasing the risk of developing intestinal cancers such as colon cancer by detoxifying 
carcinogenic compounds and toxic substances, assisting in the breakdown of anti-
nutritional factors (including trypsin inhibitors and glucosinolates) and modulation of 
feacal procarcinogenic enzymes such as β-glucuronidase, azoreductase and 
nitroreductase. 
• Promotion of tumor suppression by aspecific stimulation of the immune system to 
produce macrophages (De Vuyst and Vandamme, 1992). 
 
LAB are generally regarded as safe (GRAS) and bacteriocins (antimicrobial peptides) produced 
by these organisms are considered safe. The use of natural antimicrobial compounds instead of 
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chemical preservatives such as benzoate and sulfur dioxide are increasing in popularity. 
Bacteriocins are heat stable, biodegradable, digestible and active at low concentrations (Jack et 
al., 1995). A number of starter cultures has been developed for the food industry. Lactic acid 
bacteria may also be used to synthesize fine chemicals and antimicrobial compounds of 
pharmaceutical importance (De Vuyst and Vandamme, 1992). The medical applications of LAB 
has not been fully explored and could become an important research field, especially with so 
many strains resistant to antibiotics.   
 
Classification  
LAB includes Enterococcus, Aerococcus, Carnobacterium, Vagococcus, Lactococcus, 
Lactobacillus, Leuconostoc, Globicatella, Oenococcus, Pediococcus, Streptococcus, 
Tetragenococcus and Weissella. Enterococci form a distinct cluster with Vagococcus, 
Carnobacterium and Tetragenococcus in the clostridial subdivision (Franz et al., 1999). LAB 
important in foods is Carnobacterium, Enterococcus, Oenococcus, Lactobacillus, Leuconostoc, 
Lactococcus, Pediococcus, Tetragenococcus, Streptococcus, Weissella and Vagococcus 
(Vandamme et al., 1996). 
 
LAB is classified as either homo- or hetero-fermentative based on the pathways used for hexose 
metabolism. Homofermentative LAB uses the Embden-Meyerhof-Parnas pathway to convert 
glucose to lactic acid (Pot et al., 1994). Homofermentative LAB, such as Carnobacterium, 
Enterococcus, Lactococcus and Streptococcus, do not ferment pentoses or gluconate.  
Heterofermentative LAB ferment carbohydrates via the 6-phosphogluconate pathway. Facultative 
heterofermentative LAB ferment hexoses to lactic acid. Obligate heterofermentative lactic acid 
bacteria convert glucose to lactic acid, CO2, ethanol or acetic acid. Facultative and obligate 
heterofermentative species ferment pentoses to lactic acid and acetic acid. Although LAB are 
microaerophilic, some strains metabolize carbohydrates in the presence of oxygen (Pot et al., 
1994).  
 
Enterococcus 
Enterococci are Gram-positive, asporogenous, catalase-negative, oxidase-negative and 
facultatively anaerobic.  The round-shaped cells occur singly, in pairs or in chains (Moreno et al., 
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2006). The cells survive heating at 60oC for 30 minutes, grow from 10 to 45oC (optimally at 
35oC), and in medium supplemented with 6.5% NaCl and at pH 9.6 (Franz et al., 1999). All 
enterococci, with the exception of Enterococcus cecorum, Enterococcus columbae, Enterococcus 
dispar, Enterococcus pseudoavium, Enterococcus saccharolyticus and Enterococcus sulfurous, 
possess the Lancefield group D antigen. Most enterococci hydrolyze aesculin in the presence of 
40% (v/v) bile salts (Hardy and Whiley, 1997).  Enterococcus faecium and Enterococcus faecalis 
are associated with the human and animal gastrointestinal tract, whereas the pigmented species 
Enterococcus mundtii and E. casseliflavus are associated with plants.  E. gallinarum and E. 
casseliflavus are distinguished from other species by being motile (Schleifer and Kilpper-Bälz, 
1987). 
 
Although enterococci, especially E. faecalis and E. faecium (to a lesser extent) has been 
associated with clinical infections and some strains has been isolated from patients diagnosed 
with endocarditis, bacteraemia and urinary tract infections, many strains are used as starter 
cultures in fermented foods (Franz et al. 1999).  The best example is E. faecium in cheese.   
Enterococci has also been included in a few probiotic preparations (Stiles and Holzapfel, 1997).  
Many strains has lipolytic and esterolytic activities (De Vuyst et al., 2003). 
 
Bacteriocins (antimicrobial peptides) has been described for almost all enterococci.  These 
peptides, generally known as enterocins, are often located on pheromone responsive conjugative 
plasmids. Pheromones, cytolysin or hemolysin production, and resistance to phagocytosis and 
adherence to epithelial cells may all contribute to virulence. Recently, more antibiotic resistant 
strains, especially against vancomycin, has been described. The association of enterococci with 
clinical specimens calls for strict rules and regulations when used as starter cultures or probiotics 
(De Vuyst et al., 2003).  
 
Streptococcus 
The genus Streptococcus originally included enterococci, lactic streptococci, pyogenic 
streptococci and virulent streptococci. The original classification was based on morphological, 
physiological, serological and biochemical characteristics (Stiles and Holzapfel, 1997). 
Differentiation into the genera Enterococcus, Streptococcus and Lactococcus was based on 
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16SrRNA sequencing and DNA homology (Schleifer and Kilpper-Bälz, 1984, 1987). Currently 
the genus Streptococcus contains the species S. pyogenes, S. mutans, S. salivarius, S. pneumoniae 
and S. thermophilus.  S. thermophilus is the only species used in food fermentations, specifically 
dairy products (Stiles and Holzapfel, 1997).   
 
Lactococcus 
Lactococci are ovoid-shaped and may form chains.  The species include Lactococcus lactis, 
Lactococcus garvieae, Lactococcus plantarum, Lactococcus raffinolactis and Lactococcus 
piscium (Pot et al., 1994). Lactococcus lactis consists of four subspecies, viz. lactis, cremoris, 
diacetylactis and hordiniae. Strains from the first two subspecies are commonly used in the dairy 
industry as starter cultures. The cells are non-motile, grow at 10oC but not at 45oC, and produce 
L(+)-lactic acid from glucose (Stiles and Holzapfel, 1997).  
 
Pediococcus and Tetragenococcus 
Pediococci are non-motile, tetrad-forming homofermentative cocci (Collins et al., 1990). The 
genus Pediococcus consists of obligate homofermenters, as well as facultative and obligate 
heterofermenters (Stiles and Holzapfel, 1997). Pediococcus damnosus is a major spoilage 
organism in beer, wine and cider, leading to diacetyl/acetoin formation which results in a buttery 
taste (Garvie, 1986b). Pediococcus acidilactici and Pediococcus pentosaceus are used as starter 
cultures in the production of sausage and silage (Hammes et al., 1990). Both species produce 
bacteriocins. Pediococci are usually associated with leuconostocs and lactobacilli (Stiles and 
Holzapfel, 1997). Pediococcus halophilus is the only species that grows in the presence of 18% 
(w/v) NaCl (Garvie, 1986b) and is used to produce soy sauce. The species has been reclassified 
as Tetragenococcus halophilus based on 16S rRNA sequencing (Collins et al., 1990).  
 
Vagococcus  
Motile cocci are grouped in the genus Vagococcus and belong to serological group N. Concluded 
from 16SrRNA analyses, vagococci are phylogenetically closer related to Enterococcus, 
Carnobacterium and Listeria than to Streptococcus and Lactococcus. Three species has been 
identified, viz. Vagococcus flavialis, Vagococcus salmoninarum and Vagococcus lutrae (Stiles 
and Holzapfel, 1997; Lawson et al., 1999).  
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Lactobacillus and Carnobacterium 
The genus Lactobacillus is strictly fermentative and has complex nutritional requirements. 
Lactobacilli are widespread in nature. The genus is divided into three groups based on 
fermentative characteristics, viz. obligate homofermentative (Group 1), facultative 
heterofermentative (Group 2) and obligate heterofermentative (group 3) (Stiles and Holzapfel, 
1997). Species in Group 1 ferments hexoses to lactic acid. Species in Group 2 ferments hexoses 
to lactic acid and may produce gas from gluconate, but not from glucose. Obligate 
homofermentative lactobacilli lack the enzymes glucose 6-phosphate dehydrogenase (G-6-PDH) 
and 6-phosphogluconate dehydrogenase (6-P-GDH). Group 2 species has both enzymes (Pot et 
al., 1994). Group 3 lactobacilli ferment hexoses to lactic acid, acetic acid and/or ethanol and 
carbon dioxide. Gas is produced from glucose. Pentoses are fermented to lactic acid and acetic 
acid via the pentose phosphoketolase pathway (Pot et al., 1994). Lactobacillus spp. are the most 
acid tolerant of all lactic acid bacteria and are used as starter cultures in many different food 
products (Stiles and Holzapfel, 1997).   
 
Lactobacillus divergens, Lactobacillus carnis and Lactobacillus piscicola, originally classified as 
Group 3, has been reclassified as Carnobacterium divergens, Carnobacterium carnis and 
Carnobacterium piscicola (Collins et al., 1987). Fermentation of glucose is predominantly 
homofermentative and the fatty acid composition differs from that of lactobacilli. 
Carnobacterium spp. are normally isolated from meat and fermented meat products (Collins et 
al., 1987). 
 
Leuconostoc, Oenococcus and Weissella 
Members of the genus Leuconostoc are facultative anaerobic, heterofermentative cocci. 
Leuconostoc produce D(-) lactate from glucose which differs from the L(+) lactate produced by 
lactococci and DL- lactate produced by heterofermentative lactobacilli.  Argenine is not 
hydrolyzed. Leuconostoc spp. is normally associated with plants and play an important role in the 
production of sauerkraut (Stiles and Holzapfel, 1997). Diacetyl is produced from the fermentation 
of citrate and dextrans from sucrose (Daeschel et al., 1987; Stiles and Holzapfel, 1997). 
Leuconostocs are also prevalent in vacuum-packed meats (Shaw and Harding, 1984). The genus 
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consists of Leuconostoc mesenteroides subsp. mesenteroides, Leuconostoc mesenteroides subsp. 
dextranicum, Leuconostoc mesenteroides subsp. cremoris, Leuconostoc paramesenteroides, 
Leuconostoc lactis, Leuconostoc carnosum, Leuconostoc gelidum, Leuconostoc fallax, 
Leuconostoc amelibiosum, Leuconostoc citreum, Leuconostoc pseudomesenteroides and 
Leuconostoc argentinum (Dellaglio et al., 1995). Leuconostoc oenos has been reclassified as 
Oenococcus oeni (Dicks et al., 1995). Leuconostoc paramesenteroides has been reclassified as 
Weissella paramesenteroides and grouped with Lactobacillus hellenica, Lactobacillus 
viridescens, Lactobacillus confusa, Lactobacillus kandleri, Lactobacillus minor and 
Lactobacillus halotolerans in the genus Weissella (Collins et al., 1993). 
 
2. BACTERIOCINS 
 
Many LAB produce bacteriocins (antimicrobial peptides) to compete against other bacteria in the 
same ecological niche. Bacteriocins are gaining interest in the midst of increased reports of 
antibiotic resistance. These peptides are cationic and amphiphilic, on average 4 kDa in size, and 
ribosomally synthesized (Moreno et al., 2006). They vary in spectrum and mode of activity, 
molecular structure and mass, thermostability, pH stability and genetic determinants (Moreno et 
al., 2006). Bacteriocins are often only active against species closely related to the producer strain, 
but a number of these peptides are active against a variety of Gram-positive and Gram-negative 
bacteria, even viruses (Messi et al., 2001). Examples of such broad-spectrum bacteriocins are 
plantaricin 35d produced by Lactobacillus plantarum (Messi et al., 2001), bacteriocin ST151BR 
produced by Lactobacillus pentosus ST151BR (Todorov and Dicks, 2004), thermophylin 
produced by S. thermophylus (Ivanova et al., 1998), enterocin CRL35 produced by E. faecium 
(Farias et al., 1996), peptide AS-48 produced by E. faecalis (Abrionel et al., 2001), a bacteriocin 
produced by Lactobacillus paracasei subsp. paracasei (Caridi, 2002) and bacteriocin ST4V 
produced by E. mundtii ST4V (Todorov et al., 2005).  
 
Classes  
Bacteriocins are divided into three classes based on structure, physicochemical and molecular 
properties (Klaenhammer, 1993). Class I bacteriocins, the lantibiotics, are small, heat stable, 
cationic, hydrophobic peptides and contain unusual amino acids. These include thioether, 
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lanthionine and 3-methyl-lanthionine amino acids that are post-translationally modified. Class II 
bacteriocins are small, heat stable, cationic, hydrophobic peptides that are not post-translationally 
modified (except for cleavage of the leader peptide). Class II bacteriocins are subdivided into 
three subclasses. Subclass IIa include pediocin-like bacteriocins with anti-listerial activity with a 
consensus sequence YGNGV in the N-terminus. Subclass IIb bacteriocins require two 
polypeptide chains for activity. Subclass IIc are bacteriocins that do not belong to the other two 
subclasses. Class III bacteriocins are large, heat-labile, hydrophilic proteins (Moreno et al., 
2006). This review will focus on class IIa bacteriocins, as most enterococci are known to produce 
class II bacteriocins (De Vuyst and Vandamme, 1994).  
 
Subclass IIa bacteriocins are the largest and most extensively studied.  They all inhibit the growth 
of Listeria spp. and are used as bio-preservatives in many different food products (Ennahar et al., 
2000). The YGNGVXaaC-motif on the N-terminal of these bacteriocins is part of a recognition 
sequence for a membrane receptor protein. Class IIa bacteriocins has a net positive charge and 
their iso-electric points vary from 8.3 to 10.0. The C-terminal domain is moderately conserved, 
hydrophobic or amphiphilic. Class IIa bacteriocins has at least two cysteines with a disulfide 
bridge. The cysteine residues are in conserved positions and the disulfide bridge forms a six-
membered ring over these two residues. Bacteriocins with more than one disulfide bond has a 
broader spectrum of activity. The N-terminus of class IIa bacteriocins has an amphiphilic 
characteristic due to β-sheets in a β-hairpin conformation. The C-terminal forms an amphiphilic 
α-helix, leaving one or two residues in the C-terminal non-helical (Ennahar et al., 2000). 
 
The majority of enterococci produce class IIa bacteriocins inhibitory to closely related Gram-
positive bacteria (De Vuyst et al., 2003). Enterocin AS-48, produced by E. faecalis S-48, was the 
first enterocin to be purified and was defined as a cyclic peptide antibiotic (Galvez et al., 1989; 
Martinez-Beuno et al., 1994). The ability of enterococci to inhibit Listeria spp. may be explained 
by the close phylogenetic relatedness between enterococci and listeriae (Moreno et al., 2006).  
 
A number of bacteriocins has been described for E. mundtii.  They are classified as class IIa and 
include mundticin ATO6 isolated from chicory endive, mundticin KS isolated from grass silage, 
and enterocin CRL35 from Argentinean cheese (Bennik et al., 1998; Kawamoto et al., 2002; 
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Saavedra et al., 2004). Mundticin ATO6 and mundticin KS are identical in mature and leader 
peptides. The mature peptide of enterocin CRL35 is identical to the mundticin KS mature 
peptide, but differs with two amino acids in the leader peptide (Zendo et al., 2005; Kawamoto et 
al., 2002). 
 
Enterococcus mundtii ST4SA produces a 3950 Da broad-spectrum antibacterial peptide active 
against Gram-positive and Gram-negative bacteria, including Enterococcus faecalis, 
Streptococcus spp., Pseudomonas aeruginosa, Klebsiella pneumoniae, Streptococcus 
pneumoniae and Staphylococcus aureus (H. Knoetze, 2006). Treatment of mundticin ST4SA 
with pepsin, Proteinase K, pronase and trypsin leads to a significant reduction in activity, while 
α-amylase treatment does not reduce activity (Todorov et al., 2005). The genes encoding 
mundticin ST4SA are located on a 50-kb plasmid (H. Knoetze, 2006). The gene cluster (mun 
locus) consists of three genes viz., munA, munB and munC. The structural gene, munA, encodes a 
58-amino-acid mundticin ST4SA precursor. The leader peptide contains 15 amino acids with a 
double-glycine processing site. MunB encodes a 674-amino-acid (ABC-transporter) protein 
involved in translocating and processing of the bacteriocin. MunC encodes the 98-amino-acid 
immunity protein. The amino acid sequence, deduced from the sequence of the mundticin ST4SA 
structural gene, is completely homologous to that of mundticin KS, mundticin AT06 and 
mundticin QU2. Mundticin ST4SA differs from enterocin CRL35 by two amino acids in the 
leader peptide, but the mature peptides are completely homologous. The ABC-transporter gene of 
bacteriocin ST4SA has 98.9% homology to mundticin KS and 99.25% homology to enterocin 
CRL35. The mundticin ST4SA immunity gene is completely homologous to the immunity gene 
of enterocin CRL35, and is 96.9% homologous to that of mundticin KS (H. Knoetze, 2006). 
Mundticin ST4 (Todorov et al., 2005) inactivates the herpes simplex viruses HSV-1 (strain F) 
and HSV-2 (strain G), a measles virus (strain MV/BRAZIL/001/91, an attenuated strain of MV) 
and a polio virus (PV3, strain Sabin). 
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Fig.1. Schematic overview of machinery for the production of class IIa bacteriocins: three 
component system (histidine protein kinase, response regulator and induction factor), synthesis, 
processing, excretion and immunity (Ennahar et al., 2000; Permission granted from Blackwell 
Publishing, Oxford, U.K.). 
 
Biosynthesis  
Class IIa bacteriocins are formed as ribosomally synthesized precursors or pre-peptides 
containing an N-terminal leader sequence (Ennahar et al., 2000). The leader sequence is removed 
when the pre-peptide is cleaved at a specific processing site. The active peptide is then exported 
by membrane translocation. The two conserved glycine residues may serve as recognition signal 
for transport. A histidine protein kinase, a response regulator and an induction factor are typical 
three-component system inducers of class IIa bacteriocin genes (Fig.1). Membrane translocation 
is mediated by two membrane-bound proteins, an ABC transporter and an accessory protein 
(except for enterocin P). The ABC transporters of Class IIa bacteriocins share no common 
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structural features. The only common features are the N-terminal region that is a hydrophobic 
integral membrane domain which carries a 150 amino acid extension and the C-terminal domain 
that contains a highly conserved ATP binding domain with 200 terminal amino acids. The N-
terminal 150 amino acid peptide cleaves the leader peptide at the double-glycine motif. The 
leader peptide serves as a recognition signal for cleavage and membrane translocation of the 
mature peptide (Ennahar et al., 2000).  Non-lanthionine containing bacteriocins has 18 to 24 
amino acid residues in their leader sequences. Possible functions of the leader peptides include 
stabilization of the pre-peptide during translocation, preventing insertion of the peptide into the 
cell membrane, maintenance of specific conformation during processing, and assisting with the 
translocation of pre-peptides by specific transport systems (Jack et al., 1995). 
 
Mechanisms and mode of action 
Class IIa bacteriocins permeabilize sensitive bacterial membranes by pore formation. This results 
in the dissipation of the proton motive force (PMF), preventing the formation of a pH gradient 
(Ennahar et al., 2000). The intracellular ATP is depleted and blocks amino acid uptake, mediated 
by active transport. Amino acid leakage can also occur via pores in the membrane. Initial class 
IIa interaction with a membrane involves electrostatic binding mediated by a putative membrane-
bound receptor-type molecule. Ennahar et al. (2000) suggested binding between positively 
charged, polar residues of class IIa bacteriocins and anionic groups in the phospholipid 
membrane (Fig. 2). Hydrophobic interactions occur in the hydrophobic domain of the C terminal 
half of the bacteriocin and the lipid acyl chains. Class IIa bacteriocins insert the C-terminal into 
the target membrane and aggregate to form water-filled pores (Ennahar et al., 2000).    
 
The YGNGV motif is recognized by a putative membrane receptor due to a β-turn structure 
which allows for correct bacteriocin positioning. The N-terminal β-sheet confers an amphiphilic 
characteristic to class IIa bacteriocins, which is important for bacteriocin-membrane interaction. 
The N-terminal region is possibly involved in a membrane-surface recognition step through 
electrostatic interactions. The central oblique orientated α-helical regions, present in nine of the 
class IIa bacteriocins, facilitates insertion of the C-terminal into the phospholipid bilayer. Class 
IIa bacteriocins contain at least one disulfide bridge. Bacteriocins with more than one disulfide 
bridge has a broader spectrum of activity (Ennahar et al., 2000). The two disulfide bridges in 
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pediocin PA-1 forces the positively charged His and Lys residues closer together and forms a 
positively charged amino acid patch and a tighter junction with negatively charged lipid head 
groups, thereby increasing bacteriocin activity (Chen et al., 1997). 
 
Bacteriocin induced cell-death occurs in a concentration- and time-dependant style. Factors 
influencing the target cell or medium also play a role. The pH of the medium affects the affinity 
of the bacteriocin. A decrease from pH 7.5 to pH 6.0 has a positive membrane binding effect and 
increases pediocin PA-1 activity (Chen et al,. 1997). Positively charged class IIa bacteriocins 
bind to negatively charged phospholipid head groups. Any environmental factor (such as change 
of pH or medium components) that changes any of these two charges affects bacteriocin binding. 
The spectrum of activity is species- and strain-specific. Bacteriocin activity depends on the whole 
sequence. Fragments of the peptide display weak or no activity (Moll et al., 1999).  
 
Regulation 
Many bacterial pathways are induced by external stimuli which are sensed and signaled by signal 
transduction systems. Two-component signal transduction systems consist of a sensor located in 
the cytoplasmic membrane and a cytoplasmic response regulator. The environmental sensor acts 
as a histidine protein kinase and modifies the response regulator protein which triggers an 
adaptive response usually by gene regulation. Response regulators bind as dimers to a specific 
site (direct or inverted repeats) present near the promoter of an operon. This structurally inhibits 
binding of RNA polymerase to the promoter region. Direct repeats has been reported upstream 
from the promoters of several inducible bacteriocin operons, suggesting a common mechanism 
for bacteriocin regulation (Diep et al., 1996).  
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Fig.2. a) Predicted structural domains of class IIa bacteriocins, b) possible interaction of domains 
with the membrane surface, c) insertion and pore formation by class IIa bacteriocins. The 
hydrophobic face of the peptide is shaded dark (Ennahar et al., 2000; Permission granted from 
Blackwell Publishing, Oxford, U.K.).   
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Resistance  
Some strains are highly tolerant to bacteriocins. Tolerance can result from exposure to 
bacteriocins. Some strains of L. monocytogenes develop resistance against nisin at high 
frequencies in commercial media and food products (Ming and Daeschel, 1993). Mutation 
frequencies depend on the strain and conditions used, particularly the bacteriocin to bacteria ratio. 
L. monocytogenes has the ability to develop resistance to class IIa bacteriocins. Cross-resistance 
against class IIa bacteriocins, nisin and the class IV leuconocin S has been observed in strains of 
L. monocytogenes and Clostridium botulinum (Song and Richard, 1997). The mechanisms 
involved in bacteriocin resistance are complex and could involve changes in structure, such as 
fatty acid and phospholipid composition. This renders the cell membrane less fluid and prevents 
insertion of the bacteriocin. Modifications of this sort are easily reverted when the strain is 
cultured in the absence of the bacteriocin. Bacteriocin producer strains has immunity genes that 
confer bacteriocin resistance to closely related bacteriocins. Genetically based resistance (other 
than immunity proteins) has not been detected in tolerant strains. The long term effects of 
bacteriocin resistance that may result in stable and viable mutants must be carefully studied 
(Ennahar et al., 2000).  
 
Immunity proteins 
Immunity proteins protect bacteriocin producer strains from their own bacteriocins (Ennahar et 
al., 2000). Immunity genes are usually co-transcribed or in close vicinity to the bacteriocin gene. 
Immunity proteins consist of 88 to 115 amino acid residues and show a high degree of specificity 
with respect to the bacteriocins they recognize. However, some immunity proteins may confer 
resistance to other closely related bacteriocins (Ennahar et al., 2000). Immunity proteins function 
by disturbing the interaction between the bacteriocin and a membrane located bacteriocin 
receptor (Johnsen et al., 2004). Immunity proteins are cationic and largely hydrophilic. Previous 
studies has suggested that these molecules are largely intracellular. Immunity proteins provide 
total protection against the producer’s own bacteriocin and often partial protection against other 
bacteriocins. LAB genera which produce bacteriocins generally possess one or more immunity 
genes for class IIa bacteriocins, providing resistance against bacteriocins from closely related 
species. These proteins render the cell resistant to closely related bacteriocins. Homology 
between immunity proteins is low, which is surprising considering the similarity between the 
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corresponding bacteriocins. This suggests that immunity proteins do not interact directly with the 
bacteriocins but rather with a target or receptor in the cell (Fig.1.) (Ennahar et al., 2000). These 
mechanisms are not fully understood. 
 
3. PROBIOTICS 
 
The concept of probiotics was introduced in 1908 when Metchnikoff described the health 
promoting benefits of fermented milks (Metchnikoff, 1908). Probiotics are defined as “live 
microbial food supplements that benefit the health of consumers by maintaining or improving 
their intestinal microbial balance” (Guarner and Schaafsma, 1998). The Food and Agriculture 
Organization of the United Nations and World Health Organization (FAO/WHO) Working group 
report (2002) added to this definition by defining probiotics as “live microorganisms, which 
when administered in adequate amounts confer a health benefit on the host”. The FAO/WHO 
Working group report defined pre-biotics as “non-digestible food components which has a 
beneficial effect on human health by selectively stimulating the growth and metabolic activities 
of one or a limited number of beneficial intestinal bacteria and thus improving the balance of the 
human intestinal microflora”. 
 
The main probiotic bacteria belong to the lactic acid bacteria group. These genera include 
Lactobacillus, Bifidobacterium, Lactococcus, Enterococcus and Streptococcus, although the first 
two strains are the most commonly used.  Other probiotics are Saccharomyces and 
Propionibacterium (Vinderola and Reinheimer, 2003). The normal microflora in the human 
gastrointestinal tract is confined to the distal small bowel and the large bowel. The stomach, 
duodenum and jejunum are not typically colonized because of the acidity in the stomach and 
peristaltic movements of the digesta. The epithelial layer is overlaid with mucus and provides a 
barrier to prevent microbes from disseminating to other organs of the body. Patients suffering 
from conditions such as lactose intolerance, diarrhea, gastroenteritis, irritable bowel syndrome, 
inflammatory bowel disease (Crohn’s disease and ulcerative colitis), depressed immune function, 
cancer and genitourinary tract infections has all been reported to benefit from probiotics (Stanton 
et al., 2005).   
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Probiotics must has GRAS status, has to survive freeze-drying, spray drying, encapsulation etc. 
during production and has to be viable and metabolically active in the gastrointestinal tract. 
Probiotics should not produce off flavour, provide at least one beneficial health promoting effect 
in humans and attach to the intestinal epithelium (Leverrier et al., 2005). Probiotic vectors 
include fermented milk products, cheese, ice creams, and buttermilks, which are the most 
popular.   
 
To assess the safety of probiotic strains they must be tested in vitro for resistance to gastric acids, 
bile acid, adhesion to mucus and human epithelial cells, antimicrobial activity against pathogens, 
competitive exclusion of pathogens, bile salt hydrolase activity and resistance to spermicides (for 
vaginal use). According to the FAO/WHO Working group report (2002), probiotic strains has to 
be tested for: 
1. Antibiotic resistance  
2. D-lactate production and bile salt deconjugation 
3. Side effects in human trials 
4. Side effects in consumers (post-market) 
5. Toxin production 
6. Hemolytic activity  
7. Lack of infectivity in immuno-compromised humans and animals.  
 
Probiotic containing foods are known as functional foods. Functional foods has health benefits 
over and above providing basic nutrition and are defined as “foods that can be satisfactorily 
demonstrated to affect beneficially one or more target functions in the body, beyond adequate 
nutritional effects, in a way relevant to an improved state of health and wellbeing and/or 
reduction of risk and disease” (Contor, 2001). Some lactic acid bacteria produce secondary 
metabolites during fermentation that has been associated with health promoting benefits. These 
metabolites include B vitamins and bioactive peptides released from food proteins (Stanton et al., 
2005). Production of vitamins by LAB increases the nutritional value of fermented foods. 
Cobalamin or vitamin B12 is exclusively of microbial origin. It is present in foods such as red 
meat and milk as a result of rumen microbial action. Vitamin B12 is a co-factor in fatty acid, 
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carbohydrate, amino acid and nucleic acid metabolism. Intestinal bacteria, such as propionic acid 
bacteria, contribute to vitamin B12 levels in humans (Stanton et al., 2005).   
  
4. STRESS AND GASTRO-INTESTINAL BACTERIA 
 
Acid, bile salts and enzymes represse the growth of most LAB. Probiotic strains prevent cellular 
and DNA damage by exerting a number of stress responses, such as the SOS, heat shock and 
stringent response. All of these responses regulate error-prone polymerases. In general these 
stress responses repair or eliminate damaged macromolecules.  
 
SOS response 
The SOS response system is induced by DNA damage and is regulated by the LexA and RecA 
proteins. The two loosely grouped categories of SOS functions are nucleotide excision repair and 
translesion synthesis. When the repressor, LexA, is inactivated, an estimated 40 genes are 
induced, resulting in SOS response. In un-induced cells the SOS-genes are expressed at basal 
levels (Matic et al., 2004). Proteolytic cleavage of LexA is induced upon DNA damage. Single-
stranded DNA is then bound to the RecA protein, which in turn acts as a co-protease. Cleavage of 
LexA also occurs when cells are exposed to UV irradiation. The SOS response is also induced 
when LexA levels decrease. LexA inactivation increases with an increase in pH and during 
ageing of colonies (Little, 1991). LexA affinity for SOS box-containing gene sets determines 
expression of the gene sets. The level of induction is controlled by the amount of single stranded 
DNA in the cell (Matic et al., 2004). The Y-family of polymerases are error-prone DNA 
polymerases that replicate damaged DNA, but cause frequent mutations. Pol IV, a dinB gene 
product, and Pol V, an umuDC operon product, are both repressed by LexA and induced during 
SOS response. Under normal conditions the mutation rates are kept as low as possible by tightly 
regulating error-prone polymerases (Foster, 2004). Overproduction of RecA, RecN and RuvAB 
proteins increases recombination efficiency and capacity. This allows for efficient repair of 
double-strand breaks and daughter-strand gaps (Matic et al., 2004).       
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General stress response  
The alternative sigma factor RpoS (σ38 or σs) is triggered by conditions that terminate growth. 
This includes starvation, high osmolarity, extreme temperatures, low pH and transition into 
stationary phase. During stationary phase the RpoS sigma factor is activated and induces a set of 
genes that direct RNA polymerase to their promoters. The RpoS regulon includes more than 70 
genes, of which most encode proteins that help the cell survive the impact from dead cells in the 
environment. RpoS is considered a master regulator of stress response (Hengge-Aronis, 2002). 
Translation of rpoS mRNA is controlled by a cascade of interacting factors, including Hfq, H-
NS, dsrA RNA, LeuO and oxyS RNA. These factors modulate the stability of secondary 
structures in the ribosome-binding region of the rpoS mRNA (Matic et al., 2004). During late 
stationary phase Pol IV is induced under positive regulation of RpoS. Pol IV is the dominant 
polymerase under starvation conditions which leads to increases in the error rate of DNA 
synthesis. Mismatch repair systems correct mismatches of newly synthesized DNA before 
mutations. During starvation mismatch repair systems are only active at low levels and this leads 
to genetic variations (Foster, 2004). Different stress conditions affect the mechanisms of σs 
control differently. A reduced growth rate stimulates rpoS transcription, while low temperature, 
high osmolarity, acidic pH and some late log-phase signals stimulate translation of rpoS mRNA. 
Exposure to stress stabilizes σs which rapidly degrades under normal non-stress conditions (Matic 
et al., 2004). The RpoS regulon is expressed in vitro during stationary growth at low pH and 
nutrient limitations.    
 
Heat-shock response 
Protein denaturation induces a heat shock response which in turn induces a set of chaperons and 
proteases involved in refolding and elimination of damaged proteins.  During chronic or acute 
stress, heat shock proteins (Hsps) are up-regulated. They function as molecular chaperones in 
regulating cellular homeostasis and promoting survival. Apoptosis (programmed cell death) 
occurs when the stress is too severe. The two main functions of stress proteins in repairing 
damaged cells are: i) participation in protein folding into correct tertiary structures and 
incorporation of polypeptides into intracellular membranes or transport across those membranes 
and ii) functioning in ubiquitin-dependant protein degradation.     
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The heat shock response induces 30 genes under control of sigma factor RpoH (σ32). The RpoH 
regulon is induced by temperature and other conditions that result in unfolding of proteins. GroE, 
part of the RpoH regulon, is induced by DNA damage, oxidative stress, antibiotics, heavy metals, 
phage infection and carbon source or amino acid starvation. GroE regulates proper protein 
folding and conformation and is required at all temperatures (Yura et al., 2000). The induction of 
the RpoS regulon results in the expression of a complex network of genes with no linked 
function, which increases the cell’s capacity to resist a variety of conditions.  
 
Stringent response 
Starvation (e.g. amino acid starvation) causes cells to down-regulate the synthesis of stable RNAs 
(rRNA and tRNA) (Chatterji and Ojha, 2001). Guanosine tetra- and (penta-) phosphate (ppGpp) 
alters RNA polymerase promoter selectivity so that transcription of stable RNAs is decreased and 
selected mRNAs are increased. ppGpp is a positive effecter of RpoS and RpoS dependant genes, 
and increases the ability of RpoS and RpoH to compete with RpoD (σ70) for RNA polymerase 
(Jishage et al., 2002). The stringent response thus enhances induction of the general stress and 
heat shock responses.  
 
Stationary cells are more tolerant to different stresses than exponential growing cells (Leverrier et 
al., 2005). Starvation of carbohydrates, oxygen or phosphate induces a non-specific sigma-B 
dependant general stress regulon that causes over-expression of a series of general stress proteins. 
This leads to a multi-tolerant stage in Bacillus subtilis (Hecker and Volker, 1998). This is not true 
for all bacteria, as starvation causes autolysis in Lactococcus lactis, Leuconostoc mesenteroides 
and Pediococcus acidilactici (Leverrier et al., 2005).  
 
Stress proteins 
Genes for stress proteins are transcribed with increased levels and activity of sigma factor 32 
(σ32). The rpoH gene encodes σ32 and transcription of σ32 is controlled by 20 heat shock proteins, 
including DnaK, DnaJ, GroEL and GroES (Craig and Gross, 1991). Sigma 32 competes with σ70 
for RNA polymerase when σ70 levels in the cell decreases. This increases the heat shock protein 
levels (Yura et al., 1993). 
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In principal, stress proteins function as molecular chaperones facilitating protein degradation. 
Molecular chaperones stabilize the partly denatured sections of proteins and assist in folding and 
refolding to their native state. Chaperones form complexes with emerging polypeptides on 
ribosomes once translation is terminated and prevents premature folding. The heat shock protein 
70 (Hsp70) family plays a major role in complex formation, transport and polypeptide folding. 
Binding of unfolded proteins and their release proceeds in an ATP-dependant cycle with hsp70 
co-operating with hsp40 and Bag-1 proteins (Fig. 3). Partially unfolded protein associates with 
the C-terminal domain of Hsp70; co-chaperone hsp40 binds and initiates dissociation of ATP 
with the N-terminal domain of hsp70, leading to a conformational change (hsp70/ADP complex). 
Hsp40 then dissociates and the BAG-1 protein binds, initiating an ADP/ATP exchange. BAG-1 
then dissociates and bound proteins are released. This cycle is called the hsp70 chaperone 
machine (Forreiter and Nover, 1998).  
 
 
Fig.3. The hsp 70 chaperone machine (adapted from Kopecek et al., 2001). 
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Hydrophobic residues on the surface of partially denatured proteins are recognized by GroEL. 
The damaged proteins are then introduced into the central cavity of the GroEL heptameric ring 
formed by 57-kDa units. This “cage” effect protects the protein from proteolytic enzymes and 
protein folding continues (Baneyx and Gatenby, 1993). Molecular chaperones take part in 
degradation of irreversibly damaged proteins. The stress protein DegP has a chaperone function 
at lower temperatures and proteolyitc function at higher temperatures. Ubiquitin binds substrate 
proteins by binding to the etha-amino groups of lysine residues in substrates. The 26S 
proteasome (multi-subunit protease) recognizes the ubiquitin side chains that form on the 
substrate proteins and breaks down the monomers. The ubiquitin is then ready for a following 
binding cycle (Muller and Schwartz, 1995; Kopecek et al., 2001).  
 
Cross-protection has been observed in various studies with different combinations of stress. Bile 
provides cross protection against heat stress in E. faecalis; while in L. monocytogenes acid stress 
provides cross-protection against heat, ethanol and osmotic stress. Ultraviolet radiation stress 
provides improved ability to survive acid, heat, ethanol and hydrogen peroxide stress in L. lactis. 
Some proteins induced during stress are the same for more than one type of stress, while other 
proteins are specific for only one type (Kim et al., 2001). During stationary phase RpoS induces 
various genes involved with stationary stress response. These gene products has a multitude of 
unrelated functions. RpoS is regulated by metabolites such as cAMP, ppGpp and other extra-
cellular factors.    
 
Acid 
Resistance to human gastric acid is an important trait of probiotic bacteria. Each day, 
approximately 2.5 liters of gastric juice is secreted in the stomach at a pH of 2 -3 (Vinderola and 
Reinheimer, 2003). Food in the stomach may has a slight buffering effect against the low pH.  
Acids passively diffuse through the cell membrane of bacteria and enter the cytoplasm. The acids 
then dissociate into protons to which the cell membrane is impermeable. This results in 
intracellular accumulation of protons and lowers the intracellular pH (pHi). The lower pHi affects 
the transmembrane pH-gradient which contributes to the proton motive force and serves as an 
energy source in various transmembrane transport processes. Acid sensitive enzymes and 
proteins are also negatively affected by cytoplasmic acidification (Van de Guchte et al., 2002). 
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Sub-lethal acidic environments can lead to an adaptive response and offers protection in later acid 
exposure. This mechanism is known as the acid tolerance response (ATR). ATR was first 
described by Goodson and Rowbury (1989) when E. coli cells adapted to normally lethal acidic 
conditions when first grown in conditions of sub-lethal acidity. Adaptation to and survival in low 
pH conditions are important for food grade and gastrointestinal bacteria. Propionibacterium 
freudenreichii subjected to extreme acid challenge dramatically changed in morphology. The 
viability of the cells did, however, not decrease and cell integrity was not compromised (Jan et 
al., 2001). Cells that did not adapt to acid conditions underwent dramatic morphological changes 
and decreased in viability when subjected to acid stress. Adapted cells retained viability and cell 
integrity (Jan et al., 2001). This adaptive response has been reported for several species, 
including Oenococcus oeni, Lactobacillus plantarum, Lactococcus lactis and Lactobacillus 
sanfranciscensis (G-Alegria et al., 2004; Alemayehu et al., 2000; De Angelis et al., 2001). The 
extra-cellular pH at which bacteria grow ranges from 1.0 to 11.0. The ability to grow at different 
pH values divide bacteria into three groups viz. neutrophiles which grow best at neutral pH, 
alkalophiles which grow best at alkaline pH, and acidophiles which grow best at low pH. 
Intracellular pH has to be maintained at approximately neutral. Membrane-bound F1F0-ATPase 
plays an important role to maintain intracellular pH (Amachi et al., 1998). The gadB-encoded 
glutamate decarboxylase and the gadC-encoded glutamate-γ-aminobutyrate antiporter are 
additional mechanisms employed to retain intracellular pH. Both mechanisms are important in 
Lactococcus lactis, as shown with mutant strains (Amachi et al., 1998; Sanders et al., 1998).     
 
Oral streptococci employ numerous mechanisms to tolerate their acidic environment. These 
mechanisms include ammonia-generating activities, proton-pumping F-ATPase and up-regulation 
of DNA, and protein repair systems. Streptococcus mutans increases the proportion of long 
chained, mono-unsaturated fatty acids in the membrane, and decreases the short-chained 
saturated fatty acids in response to acidification. The organism is rendered acid sensitive if the 
ability to alter fatty acid composition is compromised (Fozo and Quivey, 2004). Membrane 
alterations (fatty acid or phospholipid compositions) are common adaptation mechanisms for 
many bacteria in response to environmental stresses.  
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F1F0-ATPase is a multimeric enzyme that synthesizes ATP by using protons or pumping protons 
out of the cell with the energy provided by ATP hydrolysis. Lactic acid bacteria increase their 
F1F0-ATPase activity at low pH to maintain the transmembrane pH gradient. The atp operon 
(encoding the F1F0-ATPase) encodes five subunits (α, β, γ, δ, ε) of the cytoplasmic F1 complex 
and three subunits (a, b, c) of the F0 membrane proton channel. In lactic acid bacteria the atp 
operons differ in their genetic organization from other bacteria, but the significance of this feature 
is unknown. Studies suggest that several ATPases with different optimum pHs exist and that a 
K+-ATPase may also be involved in maintaining optimum intracellular pH (Van de Guchte et al., 
2002). During environmental stress the cell membrane is usually the first target and changes in 
the fatty acid composition of the membrane is a general response.  
 
Bile 
A probiotic bacterium must be able to resist the deleterious effects of bile to successfully colonize 
the intestine. The human liver secretes as much as one liter of bile per day which is released into 
the intestinal tract exposing bacteria to a serious challenge. The relevant bile concentrations in 
humans range from 0.3% to 0.5% (v/v). Bile is isotonic with plasma and has an osmolarity of 
approximately 300 mOsm/ kg, which is attributable to the osmotic activity of the inorganic ions. 
Bile is amphipatic and plays a key role in the solubilization and emulsification of lipids. It also 
functions as an excretory fluid by eliminating substances that cannot be excreted in urine 
(because of bound proteins or insolubility). Bile can affect the phospholipids and proteins in the 
bacterial cell membrane and disrupt cellular homeostasis (Begley et al., 2004).  
 
Bile is synthesized in the pericentral hepatocytes of the liver and is secreted into thin channels 
called bile canaliculi, which drain into bile ducts that merge to form hepatic ducts. Bile leaves the 
liver through the common hepatic duct that joins the cystic duct from the gal bladder to form the 
common bile duct (Begley et al., 2004). Bile then enters the duodenum at a junction regulated by 
the sphincter of Oddi. Chyme from an ingested meal enters the duodenum and acid and partially 
digested fats stimulate cholecystokinin and secretin secretion. Secretin stimulates biliary ducts to 
secrete bicarbonate and water which expands the volume of the bile. Cholecystokinin stimulates 
contractions of the gallbladder and the common bile duct. The gallbladder contracts, the sphincter 
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of Oddi relaxes and up to 80% of the gallbladder contents are released into the duodenum 
(Begley et al., 2004).   
 
Bile is yellow-green in colour and consists of organic and inorganic substances, including bile 
acids, cholesterol, phospholipids (mainly phosphatidylcholine) and the pigment biliverdin. Mucus 
and immunoglobulin A are secreted into bile to prevent bacterial growth and adhesion. 
Tocopherol may also be present to prevent oxidative damage to the biliary and small intestine. 
Endogenous substances (endobiotics) such as lipovitamins (biologically active forms of vitamin 
D2), water-soluble vitamins (mainly vitamin B12, folic acid and pyrodoxine), estrogenic steroids, 
progesterone, testosterone, corticosteroids and essential trace metals may be secreted into the bile 
and undergo enterohepatic cycling (Carey and Duane, 1994). Many exogenous substances 
(xenobiotics) are also secreted into bile (e.g. commonly used drugs and antimicrobial substances) 
and undergo some degree of enterohepatic cycling. All bile acids are conjugated before secretion 
as N-acyl amidates (peptide linkage) with glycine (glycoconjugated) or taurine (tauroconjugated). 
The ratio of glycoconjugates to tauroconjugates in human bile is usually 3:1. Conjugation lowers 
the pKa of the terminal acidic group and allows the bile acids to be freely soluble over a wide 
range of ionic strengths, calcium concentrations and pH values.     
 
Bacteria in the caecum and colon transform conjugated bile acids. The main alterations include 
deconjugation (cleavage of the amino acid side chain), 7α-dehydroxylation (replacement of a 
hydroxyl group with hydrogen) and 7α-dehydrogenation. Other modifications include 
hydroxylation (replacement of hydrogen with a hydroxyl group), epimerization (inversion of the 
stereochemistry of the hydroxyl groups at C-3, C-7 and C-12), oxidation (expulsion of H2) and 
reduction (insertion of H2). Primary bile acids (from cholesterol in the liver) are modified by 
bacterial enzymes in the intestine into secondary bile acids. Some of these secondary bile acids 
are potentially mutagenic and toxic (Begley et al., 2004).  Bile salt hydrolases (BSHs) are 
catalytic enzymes that hydrolyze the amide bond between the amino acid side chain and the C-24 
position of the steroid moiety of bile acids. The enzymes are intracellular and oxygen insensitive, 
has a slightly acidic optimal pH (between pH 5 and 6), their activity is coupled to biomass 
production and they are not regulated by bile salts. Three hypotheses has been formulated to 
explain the ecological significance of BSH activity. The first hypothesis suggests a nutritional 
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advantage on hydrolytic strains. The liberated amino acids can be used as carbon, nitrogen and 
energy sources but some studies (Tannock et al., 1989) has shown that this is not a universal 
function of BSHs. The second hypothesis proposes that BSHs facilitate incorporation of 
cholesterol or bile into the bacterial membrane. This may strengthen the membranes, affect 
fluidity or charge, and could lead to increased protection against host defense mechanisms. 
Finally, deconjugation of bile salts may be a detoxification mechanism where BSH enzymes play 
a role in bile tolerance and consequently survival in the gastrointestinal tract. The exact role of 
BSHs is, however, unknown. BSH-active bacteria in the intestine has a positive cholesterol 
lowering effect on the host, but modification of unconjugated bile salts may generate toxic 
compounds that has a negative effect on the host (Begley et al., 2004).   
 
Bacterial membranes are more resistant to the negative effects of bile after acid adaptation, entry 
into stationary phase or increased osmolarity. Loci in bile sensitive mutants that are disrupted 
when coming into contact with bile are associated with the maintenance of membrane integrity.  
Bile alters membrane integrity and electron microscopy has shown that cells become shrunken 
and empty after exposure to bile, while enzyme assays has indicated leakage of intracellular 
material (Begley et al., 2004). High bile salt concentrations rapidly dissolve membrane lipids and 
dissociate integral membrane proteins. Low concentrations may disrupt membrane integrity 
through subtle effects on membrane permeability and fluidity, altered activity of membrane 
bound enzymes and transmembrane flux of divalent cations (Heuman et al., 1996). Conjugated 
bile acids are strong acids and are fully ionized at physiological pH values and remain in the 
outer hemileaflet of the lipid bilayer. Unconjugated bile acids flip-flop passively across the lipid 
bilayer and enter the cell (Cabral et al., 1987).     
 
Membrane structure and composition plays a major role in bile resistance. Altering membrane 
characteristics such as charge, lipid fluidity and hydrophobicity, or injury of the cell membrane 
(by freezing) may significantly increase susceptibility to bile. Carbon dioxide significantly 
reduces tolerance to bile salts in cells. Temperature downshifts (from 37o to 25o) that alter fatty 
acid composition renders cells more resistant to bile. Growth in the presence of Tween 80 
enhances bile tolerance in some strains and produces strain-specific changes in fatty acid 
composition (Begley et al., 2004). Bile acids also disturb macromolecule stability; alter the 
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conformation of proteins inducing misfolding and denaturation, and cause oxidative stress 
through generation of oxygen-free radicals. Molecular chaperones such as DnaK and GroESL has 
been shown to be induced by bile stress. Other promoters induced by bile include those that are 
also induced by oxidative stress (micF and osmY in E. coli). Bile chelates calcium and iron, 
leading to low intracellular calcium and iron concentrations (Begley et al., 2004).  
 
Gram-negative bacteria are inherently more resistant to bile than Gram-positive bacteria. Bile 
salts are often used in the selective enrichment of growth media for Gram-negative bacteria. 
Gram-negative bacteria possess multi drug resistance (MDR) transporters that extrude bile from 
the cell along with other toxic compounds such as antibiotics and organic solvents. The role of 
these efflux systems in bile resistance in Gram-positive bacteria has not been determined (Van de 
Guchte et al., 2002). Activity of MDR transporters depends on the proton motive force or ATP 
hydrolysis and is part of the ABC transporter super-family. Resistance to bile is one of the 
selective criteria for probiotic Gram-positive bacteria. Bile tolerance is strain specific. Various 
studies has shown the variability of tolerance within a species and genus. Bile stress is complex 
and a variety of proteins are involved, many of which will preside over cell envelope architecture 
or maintenance of intracellular homeostasis. Proteins that transport bile salts and enzymes that 
modify and transform bile salts are also likely to play central roles. Studies with Two-
dimensional-PAGE analysis revealed an increase in production of 45 proteins in E. faecalis 
during bile salt treatment (Flahaut et al., 1996). Seven general stress proteins were identified 
including the molecular chaperones DnaK, GroEL and Ohr (an organic hydroperoxide resistance 
protein). DNA repair proteins (MutS and SbcC), oxidative response (NifJ), transcription 
regulation, dGTP hydrolysis (Dgt), membrane composition (YvaG) and cell wall synthesis 
(SagA) proteins are encoded in loci that are disrupted in bile sensitive mutants (Begley et al., 
2004).   
 
Mechanisms used by bacteria to respond to bile may be similar to mechanisms used for other 
stress responses. A two-component system consisting of a histidine kinase and a cytoplasmic 
response regulator could be used to sense bile. Histidine kinase measures the presence of the 
environmental parameter (bile), senses a change and signals a response regulator which then 
instructs the cell to respond. Binding of signal molecules such as bile leads to a conformational 
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change in the sensing protein which then activates gene transcription. Disruption of cell 
membrane integrity or accumulation of damaged proteins as a result of exposure to bile could 
lead to an indirect response and induce genes involved in stress responses (Begley et al., 2004). 
 
Enteric pathogens also use bile as an environmental cue to determine location and influence 
regulation of virulence genes. During colonization and infection of a host, bacteria continuously 
monitor their environment. Virulence factors are regulated by environmental factors such as acid, 
temperature and osmolarity. It is also likely that some of the gene products involved in bile 
tolerance will assist in survival and colonization of the intestinal tract, functioning as virulence 
factors (Mekalanos, 1992). Enterococcus faecalis grown in bile has altered physicochemical 
surface properties which results in increased invasion of biliary drain materials (Waar et al., 
2002). Research on bile may explain chronic infections such as Salmonella typhi in the 
gallbladder and provide insight into pathogenic survival mechanisms in vivo. Antimicrobial 
agents combined with bile salts are very effective in the topical treatment of sexually transmitted 
diseases (Herold et al., 1999).  Compounds could be designed to inhibit bile-efflux pumps, but it 
should be borne in mind that this could inhibit the natural intestinal microflora. Studying the 
relationship of bile stresses and other stresses can lead to better probiotic development. Pre-
exposing strains to sub lethal bile conditions may also improve bile tolerance when ingested. 
Stimulation of BSH activity in probiotic strains lead to lower host cholesterol levels, which can 
be used as a biological alternative to other cholesterol lowering drugs. Research on bile may lead 
to development of better probiotics. Knowledge on regulatory pathways controlling bile stress is 
limited.  
 
Human Pancreatic juice 
Pancreatic juice has a pH above 8 and contains electrolytes and enzymes. Pancreatic juice has an 
intrinsic antimicrobial activity. However, infections are caused by Gram-negative bacteria such 
as E. coli, Klebsiella pneumoniae, Pseudomonas aeruginosa and other pathogens such as 
Enterococcus faecalis, Proteus mirabilis and Staphylococcus aureus.   
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5. REAL-TIME POLYMERASE CHAIN REACTION 
 
Kary Mullis revolutionized molecular science when he developed the polymerase chain reaction 
(PCR) method in the 1980s allowing the amplification of specific pieces of DNA to more than a 
billion fold. The first demonstration of real-time PCR was by Higuchi and co-workers in 1993, 
when they added ethidium bromide to the PCR reaction and ran the reaction under ultraviolet 
light enabling them to visualize and record the accumulation of DNA during the run (Highuchi et 
al., 1993). Real-time PCR was developed with the help of real-time videography in the early 
1990s. The methods involve the use of fluorogenic probes that reports the concentration (level) of 
amplified DNA in each cycle. Quantitative PCR refers to the ability to quantify the initial amount 
of a specific DNA sequence.  
 
DNA polymerase limits PCR because it uses DNA as template. Reverse transcriptase enzymes 
overcome this problem by generating a complementary cDNA strand from a RNA template. 
These reverse transcriptase enzymes are used by retroviruses in nature to generate DNA from 
viral RNA. Under specific reaction conditions the level of cDNA generated by reverse 
transcription is proportional to the level of its RNA template. cDNA can be used as template in 
real-time PCR to determine changes in expression levels of specific genes. This is called real-
time (RT-PCR). Because of the sensitivity and accuracy of this method even slight changes in 
expression levels are detected (Valasek and Repa, 2005). When using DNA-binding dyes such as 
SYBR green I, a two step protocol may be preferred because it is easier to eliminate primer-dimer 
formation through manipulation of melting temperatures. One-step RT-PCR minimizes 
experimental variation, since both enzymatic reactions (from cDNA synthesis to PCR 
amplification) take place in the same tube. RNA used during one step procedures as a template is 
rapidly degradable and this method may not be ideal when analyzing samples over a period of 
time.  
 
One-step protocols are also reported to be less sensitive than two-step protocols. During two-step 
reactions reverse transcription and PCR occur in separate tubes. The reverse transcriptase process 
is a highly variable reaction and using dilutions from the same cDNA template ensures that 
reactions from subsequent assays has the same amount of template as those assayed earlier. Two-
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step real-time PCR data is more reproducible than one-step RT-PCR procedures. However, two-
step procedures allow for more cross contamination in RT-PCR (Wong and Medrano, 2005).   
 
Synthesis of cDNA from RNA is an important step in real-time RT-PCR and can, if not 
conducted under stringent conditions, lead to variation in reproducibility. Variability in RNA 
quality results from the unstability of RNA once extracted and the fact that the dynamic state of 
cells differ in different biological samples. The efficiency of RNA to cDNA conversion is 
dependant on template abundance. Different priming methods can be used to synthesize cDNA, 
e.g. with random primers, oligo-dT, target gene-specific primers or a combination of oligo-dT 
and random primers. Random primers prime the RT reaction at multiple origins along every 
RNA template and produce more than one cDNA target per original mRNA target. The rRNA 
(ribosomal RNA) is the largest part of total RNA and cDNA may be synthesized un-
proportionately if the mRNA target is present at low levels (Bustin et al., 2005). Random primers 
has been shown to overestimate mRNA copy numbers by as much as 19-fold (Zhang and Byrne, 
1999). Oligo-dT priming is more accurate than random hexamers and is the best method when 
trying to amplify several target mRNAs from a limited RNA sample. Oligo-dT priming requires 
full length RNA, with no secondary structures present and RT may fail if the primer binding site 
is at the extreme 5’-end of a long mRNA. Some RT-PCR reactions use both oligo-dT and random 
hexamer primers. Target-specific primers synthesize the most specific cDNA and may result in 
the greatest sensitivity for quantitative assays. It may be restrictive when only limited levels of 
RNA are available. This method requires separate priming reactions for each target and the same 
preparation cannot be used to amplify other targets at a later stage. Multiplexing (amplifying 
more than one target in a single reaction tube) is possible when experiments are carefully 
designed and optimized. If the target is present at very low amounts, random priming may be a 
better option than specific priming. Primers must be designed to maximum amplification 
efficiencies and be target-specific for the PCR step. Melting curve analysis and SYBR green I 
chemistry can be used to verify specificity. Primer design software is available to assist in 
optimum primer design (Bustin et al., 2005).     
 
DNA amplification is monitored by using fluorescent probes. Fluorescent probes include DNA 
binding dyes such as ethidium bromide and SYBR green I, hydrolysis probes (5’-nuclease 
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probes), molecular beacons, hybridization probes, sunrise and scorpion primers and peptide 
nucleic acid (PNA) light up probes (Fig.3). Each type of probe has a unique method of 
fluorescence. SYBR green I has a 1000-fold greater fluorescence when bound to the minor 
groove of dsDNA compared to when in solution. SYBR green I binds dsDNA and fluorescence 
increases in proportion to the increase in dsDNA. This method’s specificity relies on its primers. 
To ensure specificity, a dissociation curve of the amplified product is analyzed to determine the 
melting point. Hydrolysis probes are sequence-specific dually fluorophore labeled DNA 
oligonucleotides. One fluorophore is the quencher (acceptor, such as TAMRA, DABCYL and 
BHQ) and the other the reporter (donor, including FAM, VIC, NED, etc.). When the quencher 
and reporter are both attached to the same short oligonucleotide the quencher absorbs the signal 
from the reporter. This is an example of fluorescence resonance energy transfer. During 
amplification the oligonucleotide is excised by DNA polymerase (5’ nuclease activity) and the 
reporter and quencher separates, resulting in the release of a fluorescent signal. This increases the 
reporter signal in correspondence to the amplification of the DNA. Hydrolysis probes allow for 
simple identification of point mutations (Valasek and Repa, 2005). Hybridization probes consist 
of two probes. One of the probes has a fluorescein donor on its 3’ end and emits a green 
fluorescent light when excited by the light source. An acceptor fluorophore is attached to the 5’ 
end and emission spectrums overlap. The acceptor fluorophore must be blocked at its 3’ end to 
prevent extension during the annealing step. Excitation of the donor results in fluorescence 
resonance energy transfer to the acceptor and the emission of red fluorescent light. The two dyes 
are separate in solution and only background fluorescence is emitted by the donor. During the 
annealing step, both probes hybridize to their target sequence in a head to tail arrangement. In 
this close proximity the fluorescein transfers its energy at a high efficiency. The fluorescent 
signal is only detected when both probes hybridize to their correct target sequences (Bustin, 
2000). TaqMan probes are sequence-specific oligonucleotides carrying a fluorophore and a 
quencher dye. The TaqMan probe hybridizes to the template between the standard PCR primers. 
The 5’ dye molecule (such as 6-FAM or 6-carboxyfluorescein) is released from the probe and the 
quenching effect (via FRET) when in close proximity to a quenching molecule such as TAMRA 
(6-carboxy tetramethyl rhodamine) (Ginzinger, 2002). Molecular beacons are dual labeled probes 
with a fluorophore attached to the 5’ end and a quencher dye attached at the 3’ end. The ends of 
the probes are complementary. When the probe is in solution the two ends of the probe hybridize 
 33
and form a stem-and-loop structure (hairpin) with the fluorophore in close proximity (Fig.4.). 
This quenches the fluorescent signal. When the probe binds to the target sequence the stem opens 
and the fluorophore and quencher separates to generate a fluorescent signal (Critical factors for 
successful real-time PCR, 2004).   
 
Fig. 4. Commonly used methods to generate a fluorescent signal in real-time PCR (Ginzinger, 
2002). A) The TaqMan probe is used in a 5’ nuclease assay to generate a signal using the 5’ to 3’ 
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exonuclease activity of Taq DNA polymerase. B) Molecular beacons use quenching action 
through a direct transfer of energy. A fluorescent signal is generated only when it is hybridized to 
the template when the distance of the 5’ dye molecule from the quencher is adequately apart. A 
hairpin structure ensures the quenching effect. C) SYBR green I DNA binding dye binds to 
double-stranded DNA and emits a fluorescent signal when exited by the light source when 
bound. Primers has to be optimized to prevent the formation of primer dimers (Ginzinger, 2002).       
 
Fluorescent values are recorded during every cycle and represent the amount of product amplified 
at a specific stage in the amplification reaction. The more template present at the beginning of the 
reaction, the fewer cycles it takes to first record the fluorescent signal as statistically significant 
above background (Gibson et al., 1996). This point is the Ct (crossing point) or threshold cycle 
and occurs during exponential phase of amplification. This value is representative of the starting 
copy number in the original template and is used to calculate experimental results.  The 
components become limiting during the plateau phase, but because the measurements are made 
during the beginning stages of the exponential phase this does not affect the quantification. Any 
quantification based on measurements of overall product yield will therefore be intrinsically 
unreliable. The Ct values are translated into a quantitative result by the construction of a standard 
curve. Standard curves are easily generated because of the linear response of fluorescence over a 
large dynamic range (Bustin, 2000).  
   
The instrumentation of real-time PCR must be able to detect the fluorescent signal and record the 
progress of the PCR. Three methods to supply excitation energy for fluorophores are by lamp, 
light emitting diode (LED) and laser. Lamps are broad spectrum emission devices, while LEDs 
and lasers are narrow spectrum devices. Detectors include charge coupled device cameras, 
photomultiplier tubes and other photodetectors. Multiple discrete wavelengths can be measured at 
once allowing running of multiple assays in a single reaction tube. The thermocycler used to 
perform the PCR must also be able to maintain a constant temperature among all sample wells. 
This is accomplished by using heated air or a heating block. Computer hardware and data-
acquisition and analysis software offers graphical outputs of assay results.  
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Quantification of RNA can be done by using absolute or relative quantification. Absolute 
quantification determines the absolute amount of target (copy number or concentration). Relative 
quantification determines the ratio between the amount of target and an endogenous reference 
molecule (housekeeping gene).  During absolute quantification an external standard is used to 
express the level of a gene as an absolute copy number. The standards are usually RNA 
molecules of known copy number and concentration. A standard curve of a range of known RNA 
standards is used to determine the concentrations of unknown samples by comparing the 
corresponding Ct values. Standards should be appropriate for the type of nucleic acid to be 
quantified. Standard and target molecules must has similar amplification efficiencies. Relative 
quantification determines the ratio between the amount of target and an endogenous reference 
gene that is present in all samples. The ratio can then be used to compare samples. Housekeeping 
(maintenance) genes are usually chosen as reference genes (Critical factors for successful real-
time PCR, 2004).  
 
Normalization serves to minimize errors resulting from sample to sample variations and 
variations in starting material. A cellular RNA that serves as an internal reference gene is used to 
normalize other RNA values. The ideal internal standard should be expressed at a constant level 
among different tissues of an organism, at all stages of development, and should be unaffected by 
experimental treatments. The reference gene should also be expressed at roughly the same level 
as the RNA under study. Commonly used endogenous reference genes are the glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) and β-actin (Bustin, 2000). Unfortunately no such stably 
expressed gene is known for bacteria, although many groups has proposed using certain genes 
such as the 16S rRNA or 23S rRNA genes. These genes are not optimal because rRNA is 
expressed at higher levels than mRNA and rRNA is closely dependant on the physiological status 
of the bacteria (Fey et al., 2004).  
 
The target and reference gene is amplified from the same sample. Amplification efficiencies 
determine the method of data analysis. If the amplification efficiencies of the target and reference 
genes are comparable (less than 10% difference) one standard curve can be constructed for both 
genes and the Ct values used to determine the amount of target from the standard curve. 
Alternatively the comparative method (∆∆Ct method) can be used, were the standard curves are 
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only used to determine amplification efficiencies initially and the amount of target is calculated 
by using the Ct values. The amplification efficiencies of the target gene and the reference gene 
must be approximately equal (Critical factors for successful real-time PCR, 2004). Amplification 
efficiency of the reaction is important to consider in the method of analysis. Without the 
appropriate correction for efficiency an overestimation of the starting concentration may be 
made. Amplification efficiency is calculated from a standard curve with the formula: exponential 
amplification = 10(-1/slope). The amplification efficiency is relatively stable in the early exponential 
phase and gradually declines to zero because of the depletion of PCR components. Calculating 
the efficiencies from raw data collection is reported to be more accurate than when collected from 
a standard curve (Wong and Medrano, 2005).  Various other methods of quantification are 
available, such as the Pfaffl model (Pfaffl, 2001) which combines the gene quantification and 
normalization into a single calculation using a mathematical model and the Q-Gene method, a 
software program calculating the mean normalized gene expression with standard errors using 
two different mathematical models (Muller et al., 2002).  
   
Most quantification methods in molecular biology are time consuming, labor intensive, 
insensitive, non-quantitative, require radio-activity, or has great cross contamination probability 
(Reischl et al., 2002). Real–time PCR assays are 10 000 to 100 000 times more sensitive than 
RNase protection assays, 1 000 times more sensitive than dot blot hybridization, and can even 
detect a single copy of a specific transcript. Real-time PCR can also detect differences between 
samples as small as 23%, requires much less RNA template than other methods of gene analysis 
and with a relatively high throughput (Wong and Medrano, 2005). The major disadvantage of 
RT-PCR is that it requires expensive equipment and reagents as well as sound understanding of 
the techniques and experimental design. Reproducibility of RT-PCR is influenced by the need to 
use two enzymatic steps, the exponential nature of the PCR and the use of small quantities of 
target molecules. The biggest limitation of RT-PCR is human error such as improper assay 
development, incorrect data analysis, and unwarranted conclusions. Real time PCR gene 
expression analysis measures mRNA levels and only suggests possible changes in protein levels 
or functions, rather than demonstrating them. Conclusions based on data derived from RT-PCR 
are best made when the biological context is well understood.        
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Abstract 
Bacteriocin ST4SA (bacST4SA), produced by Enterococcus mundtii ST4SA, 
inhibits the growth of Enterococcus faecium HKLHS.  The antimicrobial effect of 
bacST4SA against strain HKLHS was tested at conditions simulating the human 
intestinal tract. E. faecium HKLHS grown in the presence of a combination of bile and 
pancreatic juice was more sensitive to bacST4SA treatment. BacST4SA was added to 
cells at a final concentration of 12800 AU/ml. The level of bacST4SA did not have a 
significant impact on HKLHS cells. Cells were more sensitive to bacST4SA when in 
early log phavee. Low concentrations (12800 AU/ml) of bacST4SA had the same 
inhibiting effect as higher concentrations (25600 AU/ml and higher), indicating that low 
levels of bacST4SA are effective for treatment of infections. Treatment of E. faecium 
HKLHS cells with bacST4SA resulted in leakage of β-galactosidase. Adsorption of 
bacST4SA to E. faecium HKLHS cells, was maximal at temperature ranges between 
25oC and 37oC (75%) Acidic pH levels of pH 4.0 to 6.0 did not have a significant effect 
on adsorption, while higher pH levels of pH 8.0 to10.0 increased adsorption to 87.5%. No 
effect on adsorption of bacST4SA to E. faecium HKLHS cells was observed in the 
presence of 0.3%, 0,5% and 1,0% ox-bile, respectively. Treatment of cells with 
pancreatic juice (3.0%. 5.0% and 10.0%) showed a significant increase in adsorption 
(100%) for all three conditions. The presence of salts such as sodium chloride, 
magnesium chloride and potassium chloride did not have an effect on adsorption of 
bacST4SA to E. faecium HKLHS. Results indicate that E. mundtii ST4SA may inhibit E. 
faecium HKLHS in the human and animal gastro-intestinal tract.    
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Introduction 
Probiotics are defined as “live microbial food supplements that benefit the health 
of consumers by maintaining or improving their intestinal microbial balance” (Guarner 
and Schaafsma, 1998). Lactose intolerance, irritable bowel syndrome, diarrhea, 
gastroenteritis and inflammatory bowel disease may be alleviated by probiotic strains of 
Bifidobacterium, Propionibacterium, Lactobacillus, Lactococcus, Enterococcus and 
Streptococcus spp. (Stanton et al., 2005). 
 
Some strains of Enterococcus faecium have been associated with infections and 
are considered as emerging pathogens (Moreno et al., 2006). They have become 
important in community- and hospital-acquired infections and super-infections such as 
bacteraemia, urinary tract and intra-abdominal infections (Moreno et al., 2005).  
 
Enterococcus mundtii ST4SA produces a 3950 Da class IIa bacteriocin, active 
against Gram-positive and Gram-negative bacteria (Knoetze, 2006) and viruses, 
including the herpes simplex viruses HSV-1 (strain F) and HSV-2 (strain G), measles 
virus strain MV/BRAZIL/001/91 (an attenuated strain of MV) and polio virus PV3, strain 
Sabin (Todorov et al., 2005), Acinetobacter haumanii 16, Bacillus cereus LMG 13569, 
Clostridium tyrobutyricum LMG 13571, Enterococcus faecalis LMG 13566, E77, E80, 
E90, E92, FA2, 20 and 21, Klebsiella pneumoniae 31, Lactobacillus sakei LMG 13558, 
Propionibacterium sp. LMG 13574, Pseudomonas aeruginosa 1, 7, Staphylococcus 
aureus 6,13 and 36, Streptococcus caprinus TS1 and TS2, Streptococcus pneumoniae 3, 
4, 27 and 29 (De Kwaadsteniet et al., 2005).   
 
Bacteriocins provide probiotic bacteria with a competitive edge to ensure survival 
in the gastro-intestinal tract. Bacteriocins are small ribosomally synthesized, cationic, 
amphiphilic antimicrobial peptides, which vary in spectrum and mode of activity 
(Moreno et al., 2006). Bacteriocins are usually only active against species closely related 
to the producer strain (Moreno et al., 2006). However, recently a number of broad-
spectrum bacteriocins have been described, viz. plantaricin 35d produced by 
Lactobacillus plantarum (Messi et al., 2001), bacteriocin ST151BR produced by 
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Lactobacillus pentosus ST151BR (Todorov and Dicks, 2004), enterocin CRL35 produced 
by Enterococcus faecium (Wachsman et al., 1999), thermophylin produced by 
Streptococcus thermophylus (Ivanova et al., 1998), Lactobacillus plantarum sp. isolated 
from ben saalga (Omar et al., 2006) and bacteriocin ST4V produced by Enterococcus 
mundtii ST4V (Todorov et al., 2005). Other bacteriocins active against gram negative 
bacteria are the bacteriocin from Lactobacillus paracasei HL32 active against 
Pophyromonas gingivalis (Pangsomboon et al., 2006), ST28MS and ST26MS produced 
by Lactobacillus plantarum isolated from molasses (Todorov and Dicks, 2004), 
broadspectrum bacteriocins isolated from boza: ST194BZ, ST242BZ, ST284BZ, 
ST414BZ, ST461BZ, ST462BZ, ST664BZ, ST712BZ and bozacin 14 (von Mollendorff 
et al., 2006) and bacteriocin produced by Lactobacillus plantarum ATCC8014 (Lash et 
al., 2005). 
 
Bacteriocins are divided into four classes based on structure, physicochemical 
properties and molecular properties (Klaenhammer, 1993). Class I bacteriocins are small, 
heat stable, cationic, hydrophobic peptides and contain unusual amino acids. Class II 
bacteriocins are subdivided into three classes. Subclass IIa include pediocin-like 
bacteriocins with anti-listerial activity with a consensus sequence YGNGV in the N 
terminus. Subclass IIb bacteriocins require two polypeptide chains for activity. Subclass 
IIc are bacteriocins that do not belong to the other two classes. Class III bacteriocins are 
large, heat-labile, hydrophilic proteins. Class IV comprises complex proteins that depend 
on a carbohydrate or lipid moiety to be fully functional (Moreno et al., 2006; Nes et 
al.,1996).   
  
Bacteriocins interact with the bacterial membrane in various ways. Specific 
targets involved in pore formation have been identified, e.g. the nisin and epidermin 
family of lantibiotics target the membrane bound cell wall precursor lipid II (Linnett and 
Strominger, 1973), while the duramycin family binds to phosphoethanolamine which 
inhibits phospholipase A2 function (Nes and Holo, 2000). The intracellular ATP levels 
are depleted and amino acid leakage occurs via pores in the membrane. Interaction with 
the membrane involves electrostatic binding mediated by a putative membrane-bound 
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receptor-type protein. The positively charged polar residues of the bacteriocin binds with 
the anionic phospholipid head groups in the membrane. The C-terminus of the 
bacteriocin inserts into the target membrane and aggregates to form water-filled pores 
(Ennahar et al., 2000). Most class II bacteriocins permeabilize sensitive bacterial cell 
walls by dissipating the proton motive force (PMF) and pore formation. Class IIa 
bacteriocin activity may depend on a mannose permease of the phosphotransferase 
system (PTS) as a target (Ennahar et al., 2000). Subclass IIb specific targets have not yet 
been identified. Subclass IIc bacteriocins act via membrane permeabilization, specific 
inhibition of septum formation and pheromone activity (Hechard and Sahl, 2002). 
Bacteriocins act in a time and concentration dependant manner (Ennahar et al., 2000).  
 
E. faecium is a common intestinal microbe in the human and animal gut (Devriese 
and Pot, 1995). It is also resistant to several antibiotics, such as ampicillin, 
streptogramins, macrolides, chloramphenicol and quinolones (Klare et al., 2001). E. 
mundtii ST4SA will have to compete with this organism in the intestine.  
 
In this study, we focused on the action of bacST4SA on E. faecium as a model 
intestinal organism in simulated gastro-intestinal conditions.  
 
Materials and Methods 
 
Bacterial strains and growth conditions. Enterococcus mundtii ST4SA isolated from 
soya beans, produces bacteriocin bacST4SA (Todorov et al., 2005; Knoetze, 2006). 
Enterococcus faecium HKLHS was used as sensitive intestinal organism (Knoetze, 
2006). Strains were stored in the presence of glycerol (15%) at -80oC. All strains were 
cultured in MRS broth (Biolab, Biolab Diagnostics, Midrand, South Africa) at 37oC. 
Oxbile (OXOID, England) and pancreatic juice (Sigma Aldrich, USA) were added to 
simulate intestinal conditions.  
 
Bacteriocin bioassay. Bacteriocin activity tests were performed on cell-free supernatants 
by using the agar-spot test method (Todorov and Dicks, 2005). Cell-free supernatants 
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were adjusted to pH 6.0 with sterile 1 M NaOH before testing. Target microorganisms 
were cultured in BHI (Biolab, Biolab diagnostics, Midrand, South Africa). Antimicrobial 
activity was expressed as arbitrary units (AU)/ml, calculated as follows: ab x 100, where 
“a” represents the dilution factor and “b” the last dilution that produces an inhibition zone 
of at least 2 mm in diameter. Activity was expressed per ml by multiplication with 100 
(Todorov and Dicks, 2005).  
 
Bacteriocin ST4SA production and purification. An overnight culture of ST4SA was 
harvested (8000 × g, 4oC, 15 min) and the supernatant adjusted to pH 6.0 with NaOH, 
treated for 10 min at 80oC, filter-sterilized and stored at 4oC. Ammonium sulfate was 
gently added to the cell-free supernatant at 4° C to a saturation level of 70% (SAMBROOK 
et al., 1989). After 4 h of vigorous stirring, the precipitate was collected (20 000 x g, 1 h, 
4° C), the pellet re-suspended in one-tenth volume 25 mM ammonium acetate (pH 6.5) 
and desalted against sterile MilliQ water using a 1.0 kDa cut-off Spectra/Por dialysis 
membrane (Spectrum Inc., CA, USA). 
 
Activity of bacteriocin ST4SA against Enterococcus faecium HKLHS. Enterococcus 
faecium HKLHS was grown to early log, mid-exponential, and stationary phavee in MRS 
broth (Biolab) and MRS broth, supplemented with 1% bile (v/v), 10% pancreatic juice, a 
combination of 1% bile (v/v) and 10% pancreatic juice, and MRS broth (Biolab) adjusted 
to pH 5.5. Cells (10ml) were harvested (8 000 x g, 5 min, 4oC), washed twice in 10ml 
physiological water, diluted and plated onto MRS agar. Incubation was at 37oC. To each 
of these samples bacST4SA was added (final concentration 25 600 AU/ml) and incubated 
at 25oC. The number of viable cells were determined by plating onto MRS agar. In a 
separate experiment, bacST4SA was added at 51 200, 25 600 and 12 800 AU/ml (final 
concentrations) to 3h, 6h and 12h-old cultures of E. faecium HKLHS in MRS broth 
(Biolab) supplemented with 1% bile (v/v) and 10% pancreatic juice (v/v). Optical density 
readings (600nm) were recorded every hour for 12 hours. An un-treated cell culture was 
used as control. The most sensitive growth condition (MRS broth supplemented with 
both 10% pancreatic juice and 1% bile) was further tested to determine if more diluted 
bacteriocin will have the same inhibiting effect on E. faecium HKLHS (Fig 3.A-C).   
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Adsorption of bacteriocin ST4SA to Enterococcus faecium HKLHS in the presence 
of oxbile and pancreatic juice. Enterococcus faecium HKLHS was grown overnight in 
MRS broth at 37oC. Cells were harvested (8000 × g, 10 min, 4oC), washed twice with  
25mM phosphate buffer (pH 6.5) and resuspended in sterile phosphate buffer to the 
original volume. Oxbile was added to cell suspensions to final concentrations of 1%, 
0.5% and 0.3% (v/v). Pancreatic juice was added to yield final concentrations of 3%, 5% 
and 10% (v/v). To these cell suspensions an equal volume of 25 600 AU/ml bacST4SA 
was added (final concentration of 12 800 AU/ml). Cells suspended in sterile distilled 
water served as control. Incubation was for 1 h at 37oC. The cells were harvested (8000 × 
g, 10 min, 4oC) and bacST4SA activity determined as described before.  
 
Adsorption of bacST4SA to E. faecium HKLHS target cells were performed 
according to the method described by Yildirim et al. (2002). The target strain E. faecium 
HKLHS was grown overnight in 10ml MRS or BHI broth at 37oC and then harvested (10 
000 x g, 15 min, 4oC). The cells were washed twice with 10 ml sterile 5 mM phosphate 
buffer (pH 6.5) and re-suspended to the original volume in the same buffer. The cell 
suspension (0.7 ml) was treated with 0.7 ml bacteriocin ST4SA (25 600 AU/ml) and 
incubated for 1h at 37oC. Cells were then harvested (10 000 x g, 15 min, 25oC) and the 
activity of unbound bacteriocins in the supernatant determined as described before. 
The percentage adsorption of bacteriocin ST4SA to the target cells was calculated 
according to the following formula: 
 
 
Effect of pH and temperature on the adsorption of bacteriocin ST4SA. Bacteriocin 
ST4SA (25 600 AU/ml) was added to E. faecium HKLHS to a final concentration of 12 
800 AU/ml. The cells were incubated for 1h at 4, 10, 25, 30, 37, 45 and 60oC and, in a 
separate experiment, at pH 2.0, 4.0, 6.0, 8.0 and 10.0. The cells were then harvested (10 
000 x g, 15 min, 25oC), the pH of the cell-free supernatant adjusted to 6.0 with sterile 1M 
NaOH and bacteriocin activity determined as described before.   
 
% adsorption = 100 – ( 
bacteriocin activity after treatment  
original bacteriocin activity  
x 100) 
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Effect of SDS, inorganic salts and organic compounds on the adsorption of 
bacteriocin ST4SA to E. faecium HKLHS. Eighteen-h-old cells of E. faecium HKLHS 
were treated with 1% (m/v) NaCl, K2HPO4, KH2PO4, MgCl2, KCl, KI, Tris, 
(NH4)3C6H5O7, CH3COONa, Na2CO3, EDTA (C10H16O8N2) and SDS, 1% (v/v) Triton X-
100, Triton X-114 and β-mercaptoethanol, and 80% ethanol, methanol and chloroform, 
respectively. Bacteriocin ST4SA (25 600 AU/ml) was added to the treated cells, as 
described before, and incubated for 1h at 37oC. The cells were then harvested (10 000 x 
g, 15 min, 25oC) and the activity of the bacteriocins in the cell-free supernatant 
determined as described before.  
 
Cell lysis. Enterococcus faecium HKLHS were grown in MRS broth and MRS broth 
supplemented with 1% (v/v) oxbile, 10% (v/v) pancreatic juice and a combination of 1% 
(v/v) oxbile and 10% (v/v) pancreatic juice, respectively. BacST4SA was added to 3h old 
cultures (final concentrations = 12 800 AU/ml) in the same growth conditions. Optical 
density readings (600nm) were taken every hour for 8 hours. 
The level of β-galactosidase secreted from damaged cells was determined as 
follows. Ten ml of a log-phavee culture of E. faecium HKLHS (OD600 = 0.8 – 1.0) was 
harvested, the cells washed twice with 10 ml 0.03 M sodium phosphate buffer (pH 6.5), 
the pellet re-suspended into 4 ml of the same buffer and divided into two equal volumes. 
The cell suspension was treated with bacteriocin ST4SA (final concentrations = 12 800 
AU/ml). After 5 min of incubation at 25oC, 0.2 ml 0.1 M ONPG (O-nitrophenyl-β-D-
galactopyranoside), dissolved in 0.03 M sodium phosphate buffer (pH 6.8), was added to 
each of the cell suspensions and the cells incubated for 10 min at 37oC. The β-
galactosidase reaction was stopped by adding 2.0 ml 0.1 M sodium carbonate. The cells 
were harvested (10 000 x g, 15 min, 25oC) and absorbance readings of the cell-free 
supernatants recorded at 420 nm. Controls were cells of E. faecium HKLHS prepared the 
same way, but not treated with bacteriocin ST4SA and the cells of E. faecium HKLHS 
mechanically broken with glass beads after 5 min (Hsu et al., 2005; Nagy et al., 2005). 
The resultant levels of β-galactosidase were determined from the standard curve prepared 
with β-galactosidase (Sigma-Aldrich, USA).  
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Results  
 
Bacteriocin production and activity. Activity of bacteriocin ST4SA produced by 
Enterococcus mundtii ST4SA in MRS broth was recorded as 25 600 AU/ml in the cell-
free supernatant (one  AU was defined as the reciprocal of the highest serial twofold 
dilution showing a clear zone of growth inhibition). After ammonium sulphate 
precipitation, an activity of 102 400 AU/ml was recorded. After dialysis the activity 
remained at 102 400 AU/ml. 
 
Determination of the effect of bacST4SA on E. faecium at different growth phavees.  
Enterococcus faecium HKLHS growth was completely inhibited when ~ 3.0 × 106 
CFU/ml were treated with bacST4SA after 3 h (early log phase), 6 h (mid-exponential 
phase) and 12 h (stationary phase) of growth in MRS broth supplemented with 10% (v/v) 
pancreatic juice, 1% (v/v) bile, both 10% (v/v) pancreatic juice and 1% (v/v) bile and at 
pH 5.5, respectively (Fig. 1.A-O, Fig. 2A-D). Cells cultured in MRS broth supplemented 
with 10% (v/v) pancreatic juice and 1% (v/v) bile (in all growth phases) were the most 
sensitive to bacteriocin treatment. Low concentrations (12800 AU/ml) of bacST4SA had 
the same inhibiting effect as higher concentrations (25600 AU/ml and higher), indicating 
that low levels of bacST4SA were effective for treatment of infections.  
 
Adsorption of bacST4SA to E. faecium HKLHS in the presence of ox-bile and 
pancreatic juice. Adsorption of bacST4SA to E. faecium HKLHS cells were maximal at 
temperature ranges between 25oC and 37oC (75%), but significantly reduced at 
temperatures of 4oC, 10oC, 45oC and 60oC. Acidic pH levels of pH 4.0 to 6.0 did not have 
a significant effect on adsorption, while higher pH levels of pH 8.0 to10.0 increased 
adsorption to 87.5%. The presence of salts such as sodium chloride, magnesium chloride 
and potassium chloride did not have an effect on adsorption of bacST4SA to E. faecium 
HKLHS.  
 
The addition of K2HPO4, KH2PO4, KI, tris-HCl, and Na2CO3 to E. faecium 
HKLHS cells increased adsorption of bacST4SA to 87.5% (Table 1). E. faecium HKLHS 
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cells treated with 2-mercaptoetanol increased adsorption to 87.5%, while other organic 
solvents such as 80% ethanol and methanol had no effect on adsorption. Treatment of cell 
walls with chloroform and SDS increased adsorption to 87.5%, while treatment with 
Triton X-100 and Triton X-114 increased adsorption to 93.75% (Table 1). 
 
E. faecium HKLHS cells in the presence of 0.3%, 0,5% and 1,0% ox-bile, 
respectively, showed no effect on adsorption of bacST4SA. Treatment of cells with 
pancreatic juice (3.0%. 5.0% and  10.0%) showed a significant increase in adsorption 
(100%) for all three conditions (Table 1).  
 
Effect of bacST4SA on E. faecium HKLHS cell membrane permeability. The level of 
β-galactosidase activity secreted from damaged cells was determined. Leakage of β-
galactosidase was observed when E. faecium HKLHS was treated with bacST4SA. This 
level of β-galactosidase leakage was significantly higher than when cells were treated 
with buffer or when cells were mechanically destroyed.  
 
Cell lysis of E. faecium HKLHS by bacST4SA. Growth of E. faecium HKLHS was 
significantly inhibited by the addition of bacST4SA after 3 h of growth. E. faecium 
HKLHS cells grown in MRS broth were the most sensitive to bacST4SA treatment. A 
20% final concentration of bacST4SA was used. Pancreatic enzymes can inhibit 
bacST4SA as these enzymes denature the protein. Pancreatic enzymes had a less 
significant effect when bacST4SA concentrations were higher. Higher concentrations of 
bacST4SA showed a more significant loss of viability in E. faecium HKLHS cells. 
 
Discussion 
 
E. faecium HKLHS cultured in MRS broth supplemented with both 10% (v/v) 
pancreatic juice and 1% (v/v) bile (in all growth phavees) was more sensitive to 
bacteriocin treatment than cells cultured in MRS broth, supplemented with 1% bile (v/v), 
10% pancreatic juice and pH 5.5, respectively. This suggests that E. faecium HKLHS 
may be sensitive to bacteriocin ST4SA produced by Enterococcus mundtii ST4SA in the 
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human gastro-intestinal tract, although other factors such as enzymes and the immune 
system response may also play a role. The bile content in the human gastro-intestinal 
tract ranges from 0.3% to 0.5% (v/v) (Begley et al., 2004). Pancreatic juice have a pH of 
8.0 and is present at 0.9% (v/v) in the human GIT. BacST4SA remained active while in 
the presence of bile and pancreatic juice. E. mundtii ST4SA should be able to inhibit 
colonization of E. faecium HKLHS in gastro-intestinal conditions.  
 
Low concentrations (12800 AU/ml) of bacST4SA had the same inhibiting effect 
as higher concentrations (25600 AU/ml and higher), suggesting that low levels of 
bacST4SA may be sufficient for treatment of infections. Low levels of bacST4SA may 
thus be effective in controlling the colonization of pathogens in the GIT and control the 
microbial population.  
 
The effect of oxbile and pancreatic juice on bacteria is an important consideration 
when developing a probiotic organism. Probiotic bacteria have to survive intestinal 
conditions and their bacteriocin activity should not be significantly inhibited by intestinal 
conditions. Probiotic bacteria should be able to compete successfully with other intestinal 
bacteria and inhibit pathogens. 
 
Effective binding of bacteriocins to target cells are important for probiotic 
bacteria to kill pathogens in the intestine. Adsorption of bacteriocins to sensitive target 
cells have been described for pediocin N5p produced by Pediococcus pentosaceus 
(Manca de Nadra et al., 1998), buchnericin LB of Lactobacillus buchneri (Yildirim et al., 
2002) and plantaricin 423 of Lactobacillus plantarum 423 (Todorov and Dicks, 2006). 
 Treatment of the sensitive target strain with 1% (w/v) SDS increased the 
adsorption of pediocin N5p, while treatment of cells had no effect on the adsorption of 
buchnericin LB (Yildirim et al., 2002). Todorov and Dicks (2006) reported that 
plantaricin 423 adsorption was affected by environmental factors such as Mn2+ (increased 
binding by 80 and 100%) and 1% SDS (increased adsorption by 25%). They also 
reported that adsorption conditions was strain specific, affected by pH, but not 
temperature or contact time (Todorov and Dicks, 2006). Yildirim and co-workers 
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reported that buchnericin LB only adsorbed to gram-positive bacteria and not gram-
negative bacteria. Adsorption was pH dependant but not time and temperature dependant. 
Treatment of cells with organic solvents, detergents and enzymes did not affect resultant 
binding of buchnericin LB (Yildirim et al., 2002). Pediocin N5p from Pediococcus 
pentosaceus adsorbs to both gram-positive and gram-negative bacteria. Mg2+ and Mn2+ 
increases pediocin binding by 80 and 100% respectively, while treatment of cells with 
1% SDS and proteolytic enzymes increased binding by 25 and 100% (de Nadra et al., 
1998). E. faecium HKLHS cells treated with organic solvents and detergents increased 
adsorption of bacST4SA. The presence of salts such as sodium chloride, magnesium 
chloride and potassium chloride did not have an effect on adsorption of bacST4SA to E. 
faecium HKLHS. These results differ slightly form the results of these previously 
mentioned studies and indicate that adsorption conditions are strain specific. 
 
Adsorption of bacST4SA to E. faecium HKLHS cells were maximal at 
temperature ranges between 25oC and 37oC (75%), which is close to the natural body 
temperature of humans. pH levels of pH 8.0 to10.0 increased adsorption to 87.5%. pH 
levels in the intestine are alkaline, which would indicate that adsorption of bacST4SA 
will be optimal in the intestine. Adsorption of bacST4SA was enhanced when in the 
presence pancreatic juice. This may be due to pancreatic enzymes making the cell 
membrane more sensitive. Bile had no significant effect on the adsorption of bacST4SA. 
These results indicate that bacST4SA should be able to successfully adsorb to bacterial 
cell membranes in the intestine. β-galactosidase leakage was significantly higher in the 
presence of bacST4SA than when cells were treated with buffer and when cells were 
mechanically destroyed. This indicates that bacST4SA effectively disrupts the cell 
membrane of E. faecium HKLHS cells, resulting in intracellular leakage and cell death. 
 
The ability of probiotic bacteria to inhibit the growth of pathogenic bacteria in the 
gut by production of bacteriocins and other antimicrobial substances are well-known. E. 
mundtii ST4SA have proven to be effective in inhibiting growth of E. faecalis HKLHS in 
simulated intestinal conditions and should be able to inhibit colonization in the 
gastrointestinal tract of humans and animals, thereby preventing disease.  
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Survival of Enterococcus faecium  HKLHS in the 
presence of bacteriocin ST4SA after 6h growth in 
pH 5.5
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Survival of Enterococcus faecium  HKLHS in the 
presence of bacteriocin ST4SA after 12h growth 
in both 1% bile and 10% pancreatic juice
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Fig. 1. A-O: Survival of Enterococcus faecium HKLHS in the presence of bacteriocin 
ST4SA. 
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Growth of Enterococcus faecium HKLHS in 10% 
pancreatic juice and 1% bile treated with 
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Fig. 2. A – D: Enterococcus faecium HKLHS treated with bacteriocin ST4SA in different 
growth conditions 
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Fig. 3. A, B and C. Enterococcus faecium HKLHS in 1% bile and 10% pancreatic juice 
treated with diluted bacteriocin ST4SA 
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Fig. 4. A-E: Enterococcus faecium HKLHS adsorption in different growth conditions. 
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Table 1. Effect of pH, temperature, SDS, inorganic salts, solvents, ox-bile and pancreatic 
juice on the adsorption of bacteriocin ST4SA to target cells of E. faecium HKLHS 
(expressed as a percentage value) 
   
 
Tested factors Bacteriocin ST4SA 
adsorption to E. faecium 
HKLHS (%) 
No chemical added 75 
NaCl 75 
K2HPO4 87.5 
KH2PO4 87.5 
MgCl2 75 
KCl 75 
KI 87.5 
Tris-HCl 87.5 
NH4-citrate 75 
Na-acetate 75 
Na2CO3 87.5 
EDTA (-Na) 75 
SDS 87.5 
Triton X-100 93.75 
Triton X-114 93.75 
2-mercaptoetanol 87.5 
80% ethanol 75 
Methanol 75 
Chlorophorm 87.5 
Ox bile 0.3% 75 
Ox bile 0.5% 75 
Ox bile 1.0% 75 
Pancreatic juice 3.0% 100 
Pancreatic juice 5.0% 100 
Pancreatic juice 10.0% 100 
4 oC 50 
10 oC 50 
25 oC 75 
30 oC 75 
37 oC 75 
45 oC 50 
60 oC 50 
pH 2.0 50 
pH 4.0 75 
pH 6.0 75 
pH 8.0 87.5 
pH 10.0 87.5 
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Table 2. Levels of β-galactosidase recorded after treatment of E. faecium HKLHS with 
bacteriocin ST4SA 
 
 
 bacST4SA Controls 
 Treated 
HKLHS with 
bacST4SA 
HKLHS + 
buffer 
Mechanical 
destroyed 
HKLHS + 
buffer 
Cell free 
supernatant of 
ST4SA 
(bacteriocin) 
β-galactosidase 
activity (420 
nm) 
0.185 0.023 0.168 0.069 
β-galactosidase 
activity 
(Enzyme Units) 
1.01 x 10-1 6.80 x 10-3 9.62 x 10-2 3.44 x 10-2 
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Effect of gastro-intestinal conditions on Enterococcus mundtii ST4SA and 
production of bacteriocin ST4SA, as recorded by real-time PCR 
 
M. Granger, C. A. van Reenen, L. M.T. Dicks 
Department of Microbiology, Stellenbosch University, 7600 Stellenbosch, South Africa 
 
Abstract 
Enterococcus mundtii ST4SA, isolated from soya-beans, produces a 3950 Da 
bacteriocin (bacST4SA) active against a variety of Gram-positive and Gram-negative 
bacteria, including human pathogens. In this study, the effect of gastro-intestinal 
conditions on the survival of strain ST4SA and production of bacST4SA was studied. 
Strain ST4SA was cultured in MRS broth at different pH and in MRS broth 
supplemented with bile, pancreatic enzymes, and contents of the stomach and small 
intestine of pigs, respectively. After 12 and 24h at 37oC, cells were harvested, RNA 
isolated and cDNA prepared. Expression of the genes encoding bacST4SA, RecA, GroES 
and 23S rRNA was studied by real-time PCR (RT-PCR). No significant up- or down-
regulation of the genes were recorded when cells were cultured under conditions of 
stress, except at pH 3.5 in which case only the RecA and GroES genes were up-regulated. 
Growth of E. mundtii ST4SA and production of bacST4SA are not affected by stress 
conditions normally found in the gastro-intestinal tract. Strain ST4SA could thus be used 
as a probiotic in humans and animals. 
 
Introduction 
Lactic acid bacteria (LAB) produce antimicrobial substances that include 
bacteriocins, lactic acid, acetic acid, hydrogen peroxide and antibiotics (O’Sullivan et al., 
2002). Strains with antimicrobial properties are used as starter cultures in a variety of 
fermented meat, dairy and vegetable products to extend shelf life (O’Sullivan et al., 
2002). Many of these strains are marketed as probiotics. However, for these strains to 
survive conditions in the human and animal gastro-intestinal tract, they have to survive 
low pH, high levels of bile salts and pancreatic enzymes, and compete with other 
intestinal micro-organisms for adhesion to epithelial cells and mucus (Leverrier et al., 
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2005). Constitutive production of a broad-spectrum bacteriocin should provide the strain 
with a competitive advantage over pathogens. 
 
Bacteriocins are small ribosomally synthesized, cationic, amphiphilic, 
antimicrobial peptides, naturally produced by microorganisms (Moreno et al., 2006). 
Bacteriocins of lactic acid bacteria vary in spectrum and mode of activity, molecular 
structure and mass, thermostability, pH range for optimal activity and genetic 
determinants (Moreno et al., 2005). These peptides are often only active against closely 
related species, but a few, including bacST4SA produced by E. mundtii ST4SA, are 
active against Gram-positive and Gram-negative bacteria and viruses (Todorov et al., 
2005). Other broad-spectrum bacteriocins include plantaricin 35d produced by 
Lactobacillus plantarum (Messi et al., 2001), bacteriocin ST151BR of Lactobacillus 
pentosus ST151BR (Todorov and Dicks, 2004), thermophylin of Streptococcus 
thermophylus (Ivanova et al., 1998), enterocin CRL35 of Enterococcus faecium (Farias et 
al., 1996), peptide AS-48 of Enterococcus faecalis (Abrionel et al., 2001) and a 
bacteriocin produced by Lactobacillus paracasei subsp. paracasei (Caridi, 2002). 
 
Enterococcus mundtii ST4SA produces a 3950 Da class IIa broad-spectrum 
antibacterial peptide (bacST4SA) active against Gram-positive and Gram-negative 
bacteria, including Enterococcus faecalis, Streptococcus spp., Pseudomonas aeruginosa, 
Klebsiella pneumoniae, Streptococcus pneumoniae and Staphylococcus aureus. 
BacST4SA inactivates the herpes simplex viruses HSV-1 (strain F) and HSV-2 (strain 
G), a measles virus (strain MV/BRAZIL/001/91, an attenuated strain of MV) and a polio 
virus (PV3, strain Sabin) (Todorov et al., 2005). The genes encoding bacST4SA are 
located on a 50-kb plasmid (H. Knoetze, 2006). 
 
Class IIa bacteriocins have strong activity against Listeria and possess the 
consensus sequence YGNGV in their N-terminus (Ennahar et al., 2000). This 
YGNGVXaaC-motif is part of a recognition sequence for a membrane receptor protein. 
Class IIa bacteriocins have a net positive charge and their iso-electric points vary from 
8.3 to 10.0. The C-terminal domain is moderately conserved, hydrophobic or 
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amphiphilic. Class IIa bacteriocins have at least two cysteines with a disulfide bridge 
(Ennahar et al., 2000).  These bacteriocins form pores in sensitive cell membranes and 
leads to dissipation of the proton motif force (PMF) (Ennahar et al., 2000). Mundticin, 
produced by some strains of E. mundtii, completely dissipates the transmembrane 
potential (Bennik et al., 1998).  
 
ST4SA is encoded in a gene cluster (mun locus) that consists of three genes; 
munA, munB and munC. The structural gene, munA, encodes a 58-amino-acid mundticin 
ST4SA precursor. The leader peptide contains 15 amino acids with a double-glycine 
processing site. MunB encodes a 674-amino-acid protein (ABC-transporter) that is 
involved in translocating and processing of the bacteriocin. MunC encodes a 98-amino-
acid immunity protein against bacST4SA. The amino acid sequence of munA is 
completely homologous to other class IIa bacteriocins, e.g. mundticin KS, mundticin 
AT06 and mundticin QU2 (H. Knoetze, 2006). BacST4SA and enterocin CRL35 differ 
with two amino acids in their leader peptides, but the mature bacteriocins are completely 
homologous (Minahk et al., 2000). The ABC-transporter gene of bacteriocin ST4SA is 
98.9% homologous to mundticin KS and 99.25% homologous to enterocin CRL35 
(Kawamoto et al., 2002; Minahk et al., 2000). MunC is completely homologous to the 
immunity gene of enterocin CRL35 and 96.9% homologous to the immunity gene of 
mundticin KS (H. Knoetze, 2006).   
 
Gene translation is usually studied by hybridization (Northern blots), RNAase 
protection assays and cDNA arrays.  These methods are time-consuming and less 
sensitive than reverse transcription real-time (RT)-PCR (Bustin, 2000). In the latter case, 
amplification of genes is quantified by fluorescent probes. The assay is rapid and detects 
a single copy of a specific transcript (Wong and Medrano, 2005). 
 
This study was conducted to determine if strain ST4SA would be able to survive 
conditions in the gastro-intestinal tract.  Production of bacST4SA and stress proteins was 
studied by RT-PCR.  
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Materials and Methods 
 
1. Bacterial strains and growth conditions 
Enterococcus mundtii ST4SA and the sensitive strain (Lactobacillus casei LHS3), 
were cultured in MRS broth (Biolab, Biolab Diagnostics, Midrand, South Africa) at 
37°C. 
 
2. Growth of strain ST4SA and production of bacST4SA under stress 
Strain ST4SA was inoculated (1.0%, v/v) into MRS broth (Biolab) adjusted to pH 
5.5, 4.5, 3.5, 2.5 and 1.5, MRS broth (Biolab) supplemented with 0.3% (v/v), 0.5% (v/v) 
and 1.0% (v/v) bile, and 0.9%, 5.0% and 10.0% (v/v) pancreatic juice, respectively. 
Growth in unmodified MRS broth (Biolab) served as control. The experiment was 
repeated in skim milk supplemented with 4.0% (v/v) bile. Changes in cell density (OD600) 
and culture pH were recorded every 2 h for 24 h. Cell numbers were determined every 4 
h by plating onto MRS agar.  Plates were incubated at 37°C and colonies counted after 
48h. 
 
In a separate experiment, strain ST4SA was inoculated (1.0%, v/v) into MRS broth 
(Biolab) adjusted to pH 5.5 and 3.5, MRS broth (Biolab) supplemented with 0.5% (v/v) 
bile, 3.0% (v/v) pancreatic juice, and a combination of 1.0% (v/v) bile and 10.0% (v/v) 
pancreatic juice, respectively. Growth in unmodified MRS broth (Biolab) served as 
control.  Cultures were incubated at 37°C and bacST4SA activity recorded after 6, 12, 18 
and 24h. At each sampling time, cells were harvested (8000 × g, 4oC, 15 min), the 
supernatant adjusted to pH 6.0 with 1N NaOH, treated for 10 min at 80oC, filter-sterilized 
and stored at 4oC. BacST4SA production was recorded by using the spot plate technique 
(Ivanova et al. 1998). Activity was expressed as arbitrary units (AU) per ml. One AU was 
defined as the reciprocal of the highest serial twofold dilution showing a clear zone of 
growth inhibition of the indicator strain (Ivanova et al., 1998). 
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In another experiment, strain ST4SA was inoculated (1.0%, v/v) in MRS broth 
(Biolab) with active-growing cells of L. casei LHS3 (106 CFU/ml) and autoclaved cells of 
LHS3, respectively. Strain ST4SA inoculated into sterile MRS broth (Biolab) served as 
control.  Incubation was at 37oC. BacST4SA activity was recorded after 8, 12, 24 and 48 
h, as described before. All experiments were done in triplicate. 
 
3.  Expression of genes encoding bacST4SA and stress proteins 
Strain ST4SA was inoculated (1%, v/v) into MRS broth (Biolab) adjusted to pH 5.5 
and 3.5, MRS broth (Biolab) supplemented with 0.5% (v/v) bile, 3.0% (v/v) pancreatic 
juice, and a combination of 1.0% (v/v) bile and 10.0% (v/v) pancreatic juice, 
respectively. Growth in unmodified MRS broth (Biolab) served as control. After 12 and 
24 h of growth, cells were harvested (8000 × g, 4oC, 15 min), treated with RNAprotect 
Bacteria Reagent (Qiagen), and total RNA isolated using the Qiagen RNeasy kit (Qiagen, 
Southern Cross Biothechnology, South Africa), according to the manufacturers’ 
instructions. Purified RNA was suspended in 30μl 0.1% DMPC 
(dimethylpyrocarbonate)-treated water. RNA concentrations were measured at 260nm 
using a NanoDrop spectrophotometer. 
 
RNA samples were treated with four units of TURBO DNase (Ambion, Southern 
Cross biotechnology), as described by the supplier.  Absence of chromosomal DNA 
contamination was confirmed by PCR. Primers listed in Table 1 were used. cDNA was 
synthesized using the Transcriptor First Strand cDNA synthesis kit (Roche Diagnostics, 
Randburg, South Africa), as described by the supplier. 
 
Primers used in real-time PCR were designed from sequences listed in GenBank, 
using Primer Designer version 1.01 (Scientific and Educational Software) and obtained 
from Inqaba Biotechnology (Pretoria, South Africa). The primers are listed in Table 1. 
 
Real-time PCR was performed using a Roche LightCycler Instrument with SYBRR 
green JumpStart™ Taq readymix (Sigma-Aldrich, South Africa) in LightCycler 
capillaries. Initial denaturation of cDNA was at 95oC for 15 min, followed by 50 cycles 
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of amplification at 50oC for 10 sec and 72oC for 15 sec. Fluorescence was recorded at 
each annealing step. A melting curve was performed at the end of each run from 95oC to 
45oC (0.2oCs-1). Amplification efficiency (E) was determined by running a standard curve 
with serial dilutions of cDNA. The following formula was used: E = [10(1/slope)-1] x 100, 
where “slope” refers to the slope of the standard curve. A threshold cycle value (Ct) was 
determined for each sample, which represents the number of cycles required to reach a 
level where the fluorescent signal is statistically higher than the background. Results 
were analyzed using the comparative critical threshold method whereby the RNA level 
was adjusted to a reference relative to an internal calibrated target RNA (reference gene), 
as described by Desroche and co-workers (2005). The following equations were used:  
∆Ct = Ct of internal control – Ct of gene of interest. 
∆∆Ct = ∆Ct of sample - ∆Ct of calibrator. 
Relative expression level = 2∆∆Ct.  
Genes were considered significantly up- or down-regulated if the relative expression 
level was at least two-fold lower or higher than that of the reference gene.  Readings were 
in triplicate on each of the three independent cultures. 
 
In a separate experiment, 50 ml of stomach and small intestine content was 
collected immediately after slaughtering of pigs and inoculated with strain ST4SA (1%, 
v/v, from 1×106 cfu/ml). The pH of the stomach and small intestine was 5.5 and 7.5, 
respectively. The control was strain ST4SA cultured in MRS broth (Biolab). All samples 
were incubated at 37oC. Total RNA was isolated from 12 and 24h old cells, cDNA 
prepared and real-time PCR performed as described before. 
 
Results and Discussion 
 
Growth of E. mundtii ST4SA in the presence of 0.3% (v/v) bile was inhibited for 
the first 6h, but recovered during the following 18h (Table 2).  Growth in the presence of 
0.5% (v/v) bile was inhibited for the first 6h, followed by a slow recovery during the next 
6 to 12h (Table 2).  Growth was severely inhibited in the presence of 1.0% (v/v) bile 
(Table 2). After 24h of growth, an eight-fold reduction in bacST4SA activity was 
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recorded in the presence of 0.3% (v/v) and 0.5% (v/v) bile, and a 16-fold reduction in the 
presence of 1.0% (v/v) bile (Table 2). 
 
Growth of strain ST4SA was inhibited at pH 2.5 (Table 2).  This may not be a 
true reflection of growth in the stomach, as ingested food has a buffering capacity. 
Concluded from the low levels of bacST4SA recorded at pH 2.5 (1 600 AU/ml), the cells 
remained viable for at least 24h. Growth at pH 5.5 was more profound than at pH 3.5 and 
cell density increased with incubation (Table 2).  BacST4SA production was repressed at 
pH 3.5 (1 600 AU/ml), but increased eight-fold to 12 800 AU/ml at pH 5.5 (Table 2). 
 
Variations in pancreatic juice (5% and 10%, v/v) had no significant impact on the 
growth of strain ST4SA.  BacST4SA production in the presence of 5% (v/v) pancreatic 
juice was very low (100 AU/ml).  No activity was recorded in the presence of 10% (v/v) 
pancreatic juice (Table 2). 
 
In the human body, approximately 2.5 liters of gastric juice is secreted in the 
stomach each day, at pH of 2-3 (Vinderola and Reinheimer, 2003). Food in the stomach 
may have a buffering effect against the low pH.  Acids can passively diffuse through the 
cell membrane of bacteria and enter the cytoplasm. Sub-lethal acidic environments can 
lead to an adaptive response and offer protection to subsequent exposure to acids (Jan et 
al., 2001). This mechanism is known as the acid tolerance response (ATR) and was first 
described by Goodson and Rowbury (1989) when E. coli cells adapted to normally lethal 
acidic conditions when first grown in conditions of sub-lethal acidity.  
 
The human liver secretes as much as one liter of bile per day which is released 
into the intestinal tract, exposing bacteria to a serious challenge. The relevant bile 
concentrations in humans range from 0.3% to 0.5% (v/v). Bile is isotonic with plasma 
and has an osmolarity of approximately 300 mOsm/ kg, which is attributable to the 
osmotic activity of the inorganic ions. Bile is amphipatic and plays a key role in the 
solubilization and emulsification of lipids. Bile can affect the phospholipids and proteins 
in the bacterial cell membrane and disrupt cellular homeostasis (Begley et al., 2004). 
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 Bacterial membranes are more resistant to bile after acid adaptation, at the onset 
of stationary growth or in the presence of increased osmolarity. Pancreatic juice has a pH 
above 8.0 and contains electrolytes and enzymes, which gives it an intrinsic antimicrobial 
activity.  
 
Concluded from results obtained in this study, strain ST4SA will survive passage 
through the stomach (low pH) and even produce low levels of bacST4SA, probably not 
higher than 1 600 AU/ml.  Growth in the small intestine may be stimulated by a slightly 
higher pH.  Despite this, the activity of bacST4SA is not expected to increase in the first 
part of the small intestine (duodenum), due to the inhibitory effect of pancreatic enzymes.  
Higher levels of bile in the duodenum will most probably also inhibit growth.  However, 
strain ST4SA may proliferate in the second part of the small intestine (jejunum and 
ileum) and produce higher levels of bacST4SA, estimated to be as high as 25 600 AU/ml. 
Better growth and increased bacST4SA production are expected in the colon at higher pH 
and lower bile concentrations.  
 
Growth of E. mundtii ST4SA in intestinal fluids from the porcine gut was similar 
to the results from laboratory media. Intestinal fluids from the stomach and small 
intestine were used, but no significant differences in gene expression levels were detected 
for the bacteriocin gene when compared to the controls. The intestinal fluids contained 
significant amounts of unidentified natural intestinal microbiota, including strains of E. 
mundtii ST4SA. These naturally occurring strains did not significantly impact on the 
expression level of the genes tested and also indicates that E. mundtii ST4SA is a natural 
intestinal bacterium and therefore makes it more suitable for use as a probiotic.   
 
BacST4SA production did not increase when strain ST4SA was grown in the 
presence of viable cells of L. casei LHS3 (Table 3). This could be because L. casei LHS3 
does not inhibit the growth of strain ST4SA. Strains that produce inhibiting substances 
might stimulate bacteriocin production. Production was lower in the presence of non-
viable cells of LHS3 (Table 3). This could be due to inhibiting substances present in cell 
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lysates. Based on these results, strain ST4SA should be able to successfully compete with 
other microorganisms in the gastrointestinal tract.   
 
No significant up- or down-regulation of bacA, recA and groES genes were 
recorded, except at pH 3.5 (Addendum A). In this case, the GroES and RecA genes were 
up-regulated. This is in agreement with previous studies on lactic acid bacteria (Beltramo 
et al., 2006). bacA was up-regulated (nine-fold) after 24h in highly acidic conditions. 
Low bacST4SA production at low pH was due to very low growth rate in acid conditions. 
Very acidic conditions significantly lowered the growth rate of E. mundtii ST4SA.  No 
significant change in bacST4SA expression was recorded at any of the other conditions, 
suggesting that bacST4SA is constituently expressed. 
 
To the best of our knowledge, this is the first report of bacteriocin gene 
expression in lactic acid bacteria with real-time PCR. Gene expression levels were stable 
in the presence of porcine intestinal fluids. No significant up-regulation was detected for 
any of the genes. This suggests that bacST4SA production is affected by factors such as 
media components and enzymatic inhibition. E. mundtii ST4SA may be used as a 
probiotic in humans and animals.  
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Table 1. Primers used in reverse transcription real-time PCR 
Primer set Sequence Product 
size (bp)
Tm (oC) Gene Genbank sequence 
accession number 
Mundticin FW 5′ –ATGTCACAAGTAGTAGGTGG- 3′ 123 58.0 Mundticin gene AB 066267 
Mundticin RV 5′ –AGCTAAATTCGCAGCAGA- 3′  123 55.0  AB 066267 
GroES FW 5′ –GTGTTCAATTGATCAAAAAC- 3′ 169 52.0 GroES gene AY 328532 
GroES RV 5′ –GCATCTTCAATACGTAGTTT- 3′ 169 54.2  AY 328532 
Mundt 23SrRNA 
FW 
5′ –ATTCGATTCCCTGAGTAGCG- 3′ 159 60.4 23SrRNA sub-
unit gene 
AJ 295311 
Mundt 23SrRNA 
RV 
5′ –TCCAAATTTCATCTACGGGG- 3′ 159 58.4  AJ 295311 
RecA FW 5′ –GGACATTGTCGGTAACCGTA- 3′ 196 60.4 RecA gene AJ 621710 
RecA RV 5′ –CTTGACCGATGCGATCTTCT- 3′ 196 60.4  AJ 621710 
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Table 2. Growth of E. mundtii ST4SA and bacST4SA production by cells exposed to 
different stress conditions  
Absorption (OD600) of E. mundtii ST4SA Bacteriocin activity (AU*/ ml) 
Time 6h 12h 18h 24h 6h 12h 18h 24h 
MRS broth 
(Biolab) 2.24 3.41 3.65 3.71 51200 51200 409600 409600
0.3% Bile 1.05 3.08 3.56 3.55 25600 25600 25600 51200 
0.5% Bile 0.9 2.45 3.3 2.7 25600 25600 25600 51200 
1.0% Bile 0.89 1.11 1.52 1.5 12800 12800 25600 25600 
pH 2.5 0.05 0.11 0.2 0.11 1600 1600 1600 1600 
pH 3.5 0.09 0.66 3.22 3.3 1600 1600 1600 1600 
pH 5.5 0.44 2.8 3.7 3.94 1600 3200 12800 12800 
Pancreatic 
juice 5% 2.94 3.52 3.29 3.59 100 100 100 0 
Pancreatic 
juice 10% 2.96 3.58 3.48 3.61 0 0 0 0 
 
*AU= Arbitrary units, one AU was defined as the reciprocal of the highest serial twofold 
dilution showing a clear zone of growth inhibition.   
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Table 3. Bacteriocin activity in the presence of L. casei LHS3  
 
E. mundtii ST4SA 
Time 
Control 
 
Viable cells of 
L. casei LHS3 
Dead cells of 
L. casei LHS3 
8h 51200 25600 400 
12h 409600 409600 6400 
24h 409600 409600 12800 
48h 204800 204800 6400 
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GENERAL DISCUSSION AND CONCLUSION 
 
A probiotic bacterium has to be tested for a variety of traits such as adhesion to mucus 
and epithelial cells, resistance to bile and gastric acids, antimicrobial activity against 
pathogens, bile salt hydrolase activity and resistance to spermicides. Survival of stress 
conditions during passage through the gastro-intestinal tract is essential for successful 
colonization in the gastro intestinal tract. Cellular stress responses are up-regulated after 
exposure to stressful conditions. Bacteria change their patterns of gene expression so that 
stress is relieved (Foster, 2004). Bacteria have several stress responses that increase 
genetic variation and can lead to a selective advantage. These mechanisms include the 
heat-shock response, the general stress response, the SOS response and the stringent 
response. The genes selected for this study was the recA and groES genes. RecA gene 
expression increases under stress conditions when bound to single stranded DNA, as part 
of the SOS stress response. The groES gene, part of the groE regulon, is also induced 
when DNA damage occurs. In this study the effects of bile, acid and pancreatic enzymes 
on the growth and gene expression of Enterococcus mundtii ST4SA was tested. 
 
Enteric microbes encounter life-threatening levels of inorganic acids (H+) in the stomach 
and a combination of inorganic and organic acids (volatile fatty acids) when in the small 
intestine. The acid stress barrier is the first host defense system against pathogens. The 
average pH in the stomach of fasting humans is approximately pH 2. Probiotic microbes 
have to develop acid resistance mechanisms to survive passage through the stomach. E. 
mundtii ST4SA survives gastric acids and remains viable when reaching the small 
intestine. Growth was not recorded at pH 2.5, but cells remained viable for 24h and 
multiplied when inoculated onto MRS agar. Growth of E. mundtii ST4SA was not 
severely inhibited at higher pH levels. Real-time PCR studies showed an increase in the 
expression of groES and recA, indicating that the cells experienced stress at low pH. This 
is expected because of DNA damage that may occur during acid conditions. The 
bacteriocin gene, bacA, was up-regulated nine-fold after 24 h at pH 3.5. The presence of 
food in the stomach and intestine creates micro-environments which enhances the 
survival of bacteria as they are not in direct contact with toxic agents.    
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Bile is antimicrobial in nature because of its strong detergent action against lipids. The 
physiological concentrations of bile in humans range from 0.3% to 0.5% (Vinderola and 
Reinheimer, 2003). Adaptation to bile salts leads to cross-protection towards acid and 
heat stress (Flahaut et al., 1996). Bile affects the phospholipids and proteins in the 
bacterial cell membrane and disrupts cellular homeostasis (Begley et al., 2004). E. 
mundtii ST4SA resists bile concentrations as high as 1.0% (v/v). Growth of E. mundtii 
ST4SA was slightly inhibited when grown in the presence of 0.3% (v/v) bile, but 
recovered after 6h. Growth in the presence of 1% (v/v) bile was severely reduced, but 
cells remained viable. This suggests that E. mundtii ST4SA will survive passage through 
the small intestine to lower parts of the duodenum to colonize the intestine. Bile tolerance 
is strain specific and tolerances of species cannot be generalized (Begley et al., 2004).  
Encapsulation of probiotic strains may also increase survival. Previous research suggests 
that bile resistance could be coupled to an ABC transporter. No real evidence of this has 
been found and further research should be done to establish the mechanisms of bile 
resistance. Bile salt hydrolase activity may also play a part in bile resistance but it has not 
been established to what degree. Previous studies in lactobacilli have not supported this 
hypothesis (Moser and Savage, 2001). This should also be studied further in E. mundtii 
ST4SA.  
 
Pancreatic juices possess an intrinsic antimicrobial activity against several bacteria. It is 
also the main pathway for antibiotic secretion from the pancreas. Bertazzoni Minelli and 
co-workers (1996) have shown that pancreatic juice has an intrinsic antimicrobial effect 
against Gram-negative bacteria, and is bactericidal at high concentrations. Pancreatic 
enzyme concentrations had no significant effect on E. mundtii ST4SA, but did inhibit 
bacteriocin production. This inhibition was not apparent with real-time PCR. This 
suggests that inhibition could have been due to inactivation of the bacteriocin protein by 
proteolytic enzymes, rather than suppression of the bacteriocin genes.  
 
Growth of E. mundtii ST4SA in intestinal fluids from the porcine gut was similar to the 
results from laboratory media. Intestinal fluids from the stomach and small intestine were 
used, but no significant differences in gene expression levels were detected for the 
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bacteriocin gene when compared to the controls. The intestinal fluids contained 
significant amounts of unidentified natural intestinal microbiota, including strains of E. 
mundtii ST4SA. These naturally occurring strains did not significantly impact on the 
expression level of the genes tested and also indicates that E. mundtii ST4SA is a natural 
intestinal bacterium and therefore makes it more suitable for use as a probiotic.   
 
The host gastrointestinal tract is exposed to numerous foreign antigens. It is embedded 
with a complex network of immunological and non-immunological mechanisms, termed 
“the mucosal barrier”. This barrier protects the host from potentially harmful pathogens 
and allows for toleration of resident microbes to allow for absorption and utilization of 
nutrients (Acheson, 2004). The mucosal immune system has to discriminate between 
harmful and beneficial agents. Some pathogens have developed ways to bypass the 
defense of the mucosal immune system, while other opportunistic pathogens take 
advantage of factors such as stress or antibiotic use which weakens the immune system. 
In these cases it would be beneficial for the host to have another mechanism of protection 
in the gut. Probiotic microbes can prevent disease in the gut and help to maintain a 
healthy mucosal immune system. Production of bacteriocins can inhibit the proliferation 
of pathogens in the intestine. Enterococcus mundtii ST4SA produces a broad spectrum 
bacteriocin with the ability to inhibit Gram-positive and Gram-negative bacteria and even 
viruses (Todorov et al., 2005). Bacteriocin BacST4SA activity and efficacy was tested 
against the common intestinal opportunistic pathogen Enterococcus faecium HKLHS. 
When there was only a very small amount of E. faecium HKLHS cells present, growth 
was completely inhibited by bacST4SA. Early log phase cells were significantly inhibited 
by bacST4SA in the presence of pancreatic juice and bile. Supplementation with bile and 
pancreatic juice rendered cells more sensitive to bacteriocin treatment. This suggests that 
pathogenic organisms will be susceptible to antimicrobial treatment when in the gut. The 
concentration of the pathogenic cells had a bigger effect on survival than the 
concentration of the bacteriocin. This suggests that treatment of infections with 
bacteriocin producing probiotics should start early in the disease before the pathogenic 
microbes colonize the intestine. A constant intake of probiotics on a daily basis will aid in 
the prevention of infections by controlling the growth of potential pathogens.  
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Adsorption of bacST4SA was tested against E. faecium HKLHS. This adsorption 
indicates the level of effectiveness of the bacteriocin, with a higher level of adsorption 
indicating higher levels of effectiveness. Incubation of cells with bacST4SA indicated 
that pancreatic juice enhances the adsorption of the bacteriocin to the cells. Bile also 
showed a 75% adsorption to the cells, indicating that bacST4SA will be effective in 
targeting the cells. Cell lysis studies showed significant reduction in growth when 
bacST4SA was added to growth media. The absorption of bacteriocins to sensitive target 
cells have been described for pediocin N5p produced by Pediococcus pentosaceus 
(Manca de Nadra et al., 1998), buchnerin LB produced by Lactobacillus buchneri 
(Yildirim et al., 2002) and plantaricin 423 produced by Lactobacillus plantarum 423 
(Todorov and Dicks, 2006). 
 
The number of genes that are up-regulated during certain stress responses vary and is 
very complex, therefore it is difficult to predict which genes will be affected during 
which stress conditions. Similar results were obtained in real-time PCR studies with 
Oenococcus oeni in stress conditions (Beltramo et al., 2006). Beltramo and co-workers 
established that a number of genes should be studied in order to establish significant 
changes in gene expression. Little information is available for the genome of E. mundtii 
ST4SA which also makes it difficult to select possible target genes for study. Further 
studies should focus on sequencing the genome of E. mundtii and then to test these genes 
during various stress responses. Further molecular studies focusing on these stress 
conditions should be done incorporating a number of genes. To the best of our knowledge 
this is the first study on the expression of the bacteriocin gene in lactic acid bacteria in 
stress conditions.   
 
Concluded from these results, E. mundtii ST4SA will survive passage through the 
stomach and small intestine and be able to colonize the lower duodenum, where higher 
pH levels prevail. Bacteriocin production is constant in these conditions and will inhibit 
pathogenic organisms in the gut, which is beneficial to the host preventing disease. 
Further studies focusing on the genetic make-up of E. mundtii ST4SA genome should be 
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done to identify genes. This study serves as a basis for further studies to focus on gene 
expression of lactic acid bacteria in the gut, as this is the first study of its kind that we are 
aware of. These gene expression studies in lactic acid bacteria will aid to develop better, 
safer and more effective probiotic supplements.  
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Addendum A 
This addendum refers to the article “Effect of gastro-intestinal conditions on Enterococcus mundtii 
ST4SA and production of bacteriocin ST4SA, as recorded by real-time PCR” on page 70. 
 
Table 1. Real-time PCR results of mundticin gene in simulated intestinal conditions 
Mundticin gene     ΔCt ΔΔCt 2^(-ΔΔCt) 
Sample 
Ct 
Mundticin Ct 23 S
Mundticin-
23S 
Sample-
calibrator 
Relative to 
calibrator 
Control 12h  22.61 17.44 5.17 0.00 1.00 
  23.04 17.62 5.42     
  27.07 20.01 7.06     
      5.88     
Control 24h 22.89 20.19 2.70 -0.07 1.05 
  24.69 16.9 7.79     
  27.26 20.2 7.06     
  25.1 19.38 5.72     
      5.82     
Bile 0.5% 12h 22.09 15.82 6.27 0.49 0.71 
  23.46 17.37 6.09     
  27.2 19.89 7.31     
  23.74 17.93 5.81     
      6.37     
Bile 0.5% 24h 21.8 18.46 3.34 -0.93 1.91 
  24.86 19.89 4.97     
  26.21 20.12 6.09     
  25.29 19.89 5.40     
      4.95     
Pancreatic 3% 
12h 25.26 16.52 8.74 0.72 0.61 
  24.74 20.62 4.12     
  26.16 19.21 6.95     
      6.60     
Pancreatic 3% 
24h 24.51 20.74 3.77 -0.06 1.04 
  25.79 19.19 6.60     
  27.76 20.36 7.40     
  25.31 19.8 5.51     
      5.82     
pH 5.5 12h 22.08 20.06 2.02 -1.52 2.86 
  23.63 18.53 5.10     
  24.66 20.9 3.76     
  25.74 19.15 6.59     
      4.37     
pH 5.5 24h 23.67 20.35 3.32 0.03 1.02 
  25.25 18.93 6.32     
  27.1 19.9 7.20     
  25.86 19.03 6.83     
      5.92     
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Table 2. Real-time PCR results of GroES gene in simulated intestinal conditions 
GroES gene     ΔCt ΔΔCt 2^(-ΔΔCt) 
Sample Ct GroES Ct 23S GroES-23S 
Sample-
calibrator 
Relative to 
calibrator 
Control 12h  15.55 17.44 -1.89 0.00 1.00 
  19.56 17.62 1.94     
      0.00     
      0.02     
Control 24h 18.65 16.9 1.75 0.15 0.90 
  18.95 20.2 -1.25     
  19.56 19.38 0.18     
      0.23     
Bile 0.5% 12h     0.00 0.99 0.50 
  19 17.37 1.63     
  19.67 19.89 -0.22     
  20.54 17.93 2.61     
      1.01     
Bile 0.5% 24h 19.32 19.89 -0.57 -0.77 1.71 
  18.87 20.12 -1.25     
  18.68 19.89 -1.21     
      -1.01     
Pancreatic 3% 
12h 19.93 16.52 3.41 0.82 0.57 
  19.59 20.62 -1.03     
  19.34 19.21 0.13     
      0.84     
Pancreatic 3% 
24h     0.00 -0.11 1.08 
  19.91 19.19 0.72     
  19.36 20.36 -1.00     
  19.72 19.8 -0.08     
      -0.09     
pH 5.5 12h 18.32 18.53 -0.21 -0.36 1.29 
  19.11 20.9 -1.79     
  19.76 19.15 0.61     
      -0.46     
pH 5.5 24h 16.52 20.35 -3.83 -1.13 2.19 
  16.83 18.93 -2.10     
  20.06 19.9 0.16     
  20.35 19.03 1.32     
      -1.11     
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Table 3. Real-time PCR results of RecA gene in simulated intestinal conditions 
RecA gene     ΔCt ΔΔCt 2^(-ΔΔCt) 
Sample Ct RecA Ct 23S RecA -23S 
sample-
calibrator 
Relative to 
calibrator 
Control 12h  16.25 17.44 -1.19 0.00 1.00 
  15.97 17.62 -1.65     
  16.06 20.01 -3.95     
      -2.26     
            
Control 24h 16.82 20.19 -3.37 0.44 0.74 
  16.71 16.9 -0.19     
  16.48 20.2 -3.72     
      0.00     
      -1.82     
Bile 0.5% 12h 16.7 15.82 0.88 1.24 0.42 
  16.06 17.37 -1.31     
  16.7 19.89 -3.19     
  17.46 17.93 -0.47     
      -1.02     
Bile 0.5% 24h 16.68 18.46 -1.78 -0.64 1.56 
  16.66 19.89 -3.23     
  16.79 20.12 -3.33     
  16.6 19.89 -3.29     
      -2.91     
Pancreatic 3% 
12h 16.79     -0.45 1.37 
  16.1 16.52 -0.42     
  16.02 20.62 -4.60     
  16.08 19.21 -3.13     
      -2.72     
Pancreatic 3% 
24h 17.08 20.74 -3.66 0.70 0.62 
  18.77 19.19 -0.42     
      0.00     
  17.63 19.8 -2.17     
      -1.56     
pH 5.5 12h 16.73 20.06 -3.33 -0.97 1.96 
  15.98 18.53 -2.55     
  16.57 20.9 -4.33     
  16.41 19.15 -2.74     
      -3.24     
pH 5.5 24h 17.83 20.35 -2.52 0.12 0.92 
  17.09 18.93 -1.84     
  16.56 19.9 -3.34     
  18.17 19.03 -0.86     
      -2.14     
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Table 4. Real-time PCR results of mundticin gene in extreme intestinal conditions 
Mundticin gene     ΔCt ΔΔCt 2^(-ΔΔCt) 
Sample Ct mundticin 
Ct 23S 
rRNA 
mundticin-
23S rRNA 
sample-
calibrator 
Relative to 
calibrator 
Control 12h 24.84 16.99 7.85 0.00 1.00
  18.52 16.14 2.38     
      5.12     
Skim milk +bile 
12h 25.63 17.69 7.94 -0.43 1.34
  20.21 18.77 1.44     
      4.69     
pH 3 12h 26.81 18.51 8.30 -0.90 1.86
  20.81 20.67 0.14     
      4.22     
Bile +pancreatic 
12h 25.2 20.14 5.06 -0.31 1.24
  21.72 17.17 4.55     
      4.81     
kontrol 24h 26.96 16.73 10.23 2.05 0.24
  19.78 15.68 4.10     
      7.17     
skim milk +bile 
24h 25.18 17.76 7.42 -0.35 1.28
  19.98 17.87 2.11     
      4.77     
pH 3 24h 25.06 20.33 4.73 -3.31 9.88
  19.65 20.76 -1.11     
      1.81     
bile +pancreatic 
24h 25.52 15.42 10.10 0.80 0.57
  18.74 17.01 1.73     
      5.92     
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Table 5. Real-time PCR results of RecA gene in extreme intestinal conditions 
RecA gene     ΔCt ΔΔCt 2^(-ΔΔCt) 
Sample Ct RecA 
Ct 23S 
rRNA 
RecA-23S 
rRNA 
sample-
calibrator 
Relative to 
calibrator 
Control 12h 17.35 16.84 0.51 0.00 1.00
  16.81 16.14 0.67     
      0.59     
Skim milk +bile 
12h 17.39 17.95 -0.56 -0.74 1.67
  16.83 18.77 -1.94     
      -0.15     
pH 3 12h 16.78 21.04 -4.26 -4.85 28.84
  16.83 20.67 -3.84     
      -4.26     
Bile +pancreatic 
12h 16.1 17.97 -1.87 -1.64 3.11
  16.95 17.17 -0.22     
      -1.05     
kontrol 24h 16.65 16.92 -0.27 -0.16 1.11
  16.82 15.68 1.14     
      0.43     
skim milk +bile 
24h 17.15 16.76 0.39 -0.82 1.77
  17.02 17.87 -0.85     
      -0.23     
pH 3 24h 17.31 20.77 -3.46 -4.21 18.44
  16.99 20.76 -3.77     
      -3.62     
bile +pancreatic 
24h 16.74 15.97 0.77 -1.20 2.29
  16.76 18.74 -1.98     
      -0.61     
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Table 6. Real-time PCR results of GroES gene in extreme intestinal conditions 
GroES gene     ΔCt ΔΔCt 2^(-ΔΔCt) 
Sample Ct GroES 
Ct 23S 
rRNA 
GroES- 
23S rRNA 
sample-
calibrator 
Relative to 
calibrator 
Control 12h 17.83 16.84 0.99 0.00 1.00
  14.25 16.14 -1.89     
      -0.45     
Skim milk +bile 
12h 18.17 17.95 0.22 0.08 0.95
  17.81 18.77 -0.96     
      -0.37     
pH 3 12h 18.17 21.04 -2.87 -1.71 3.27
  19.22 20.67 -1.45     
      -2.16     
Bile +pancreatic 
12h 17.73 17.97 -0.24 -0.17 1.13
  16.16 17.17 -1.01     
      -0.63     
kontrol 24h 17.3 16.92 0.38 0.94 0.52
  16.28 15.68 0.60     
      0.49     
skim milk +bile 
24h 15.27 16.76 -1.49 -0.31 1.24
  17.84 17.87 -0.03     
      -0.76     
pH 3 24h 17.5 20.77 -3.27 -3.54 11.63
  16.05 20.76 -4.71     
      -3.99     
bile +pancreatic 
24h 15.73 15.97 -0.24 -0.25 1.19
  17.57 18.74 -1.17     
      -0.70     
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Table 7: Real time PCR results of mundticin gene in pig intestinal fluids 
Mundticin gene     ΔCt ΔΔCt 2^(-ΔΔCt) 
Sample Ct mundticin Ct 23 S
mundticin-
23S 
sample-
calibrator 
Relative to 
calibrator 
Control 12h 20.53 20.35 0.18 0.00   
  20.92 19.53 1.39     
  20.43 20.27 0.16     
  20.93 19.29 1.64     
      0.84     
Control 24 h 20.80 18.16 2.64 1.01 0.50
  21.87 20.48 1.39     
  20.84 18.59 2.25     
  21.80 20.70 1.10     
      1.85     
Stomach control 
12h 21.58 20.59 0.99 0.15 0.90
      0.99     
Stomach control 
24h 20.48 20.52 -0.04 -0.88 1.84
      -0.04     
Stomach 12h  21.79 20.29 1.50 1.08 0.47
  21.30 19.47 1.83     
  21.66 19.23 2.43     
      1.92     
Stomach 24h 21.23 19.09 2.14 0.25 0.84
  19.15 20.30 -1.15     
  22.01 19.72 2.29     
      1.09     
Intestine control 
12h 20.73 20.08 0.65 -0.19 1.14
      0.65     
Intestine control 
24h 21.49 20.12 1.37 0.53 0.69
      1.37     
Intestine 12h 20.97 19.83 1.14 -0.31 1.24
  20.75 20.71 0.04     
  20.69 20.27 0.42     
      0.53     
Intestine 24h 20.81 20.71 0.10 0.84 0.56
  20.63 20.11 0.52     
  21.60 20.15 1.45     
      0.69     
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Table 8. Real time PCR results of RecA gene in pig intestinal fluids 
RecA gene     ΔCt ΔΔCt 2^(-ΔΔCt) 
Sample Ct RecA Ct 23 S
RecA-
23S 
sample-
calibrator 
Relative to 
calibrator 
Control 12h 16.54 20.53 -3.99   1.00 
  15.78 20.01 -4.23     
  16.18 20.77 -4.59     
  16.81 20.23 -3.42     
      -4.06     
Control 24 h 16.16 18.73 -2.57 0.77 0.59 
  16.00 18.94 -2.94     
  16.63 20.98 -4.35     
      -3.29     
Stomach control 12h 16.06 21.02 -4.96 -0.90 1.87 
            
Stomach control 24h 16.18 20.85 -4.67 -0.61 1.53 
            
Stomach 12h  15.68 20.56 -4.88 0.22 0.86 
  16.59 19.88 -3.29     
  16.19 19.55 -3.36     
      -3.84     
Stomach 24h 16.69 19.79 -3.10 0.18 0.88 
  16.54 20.95 -4.41     
  15.95 20.08 -4.13     
      -3.88     
Intestine control 12h 16.48 20.10 -3.62 0.44 0.74 
      -3.62     
Intestine control 24h 15.57 20.41 -4.84 -0.78 1.72 
      -4.84     
Intestine 12h 16.29 20.20 -3.91 -1.16 2.24 
  15.54 23.23 -7.69     
  16.07 20.12 -4.05     
      -5.22     
Intestine 24h 15.36 20.79 -5.43 -0.10 1.07 
  17.13 20.47 -3.34     
  16.37 20.09 -3.72     
      -4.16     
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